@prefix : <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#> .
@prefix dc: <http://purl.org/dc/elements/1.1/> .
@prefix mp: <http://purl.org/mp/> .
@prefix oa: <http://www.w3.org/ns/oa#> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix core: <http://purl.obolibrary.org/obo/uberon/core#> .
@prefix foaf: <http://xmlns.com/foaf/0.1/> .
@prefix pato: <http://purl.obolibrary.org/obo/pato#> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix core1: <http://purl.obolibrary.org/obo/core#> .
@prefix terms: <http://purl.org/dc/terms/> .
@prefix uberon: <http://purl.obolibrary.org/obo/uberon#> .
@prefix subsets: <http://purl.obolibrary.org/obo/ro/subsets#> .
@prefix oboInOwl: <http://www.geneontology.org/formats/oboInOwl#> .
@prefix OpenPVSignal: <http://purl.org/OpenPVSignal/OpenPVSignal.owl#> .
@base <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl> .

<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl> rdf:type owl:Ontology ;
                                                                           owl:imports <http://purl.org/OpenPVSignal/OpenPVSignal.owl> ,
                                                                                       mp: ;
                                                                           rdfs:isDefinedBy "https://apps.who.int/iris/handle/10665/326784"^^xsd:anyURI ;
                                                                           rdfs:label "Methylphenidate and lockjaw"^^xsd:Literal ;
                                                                           owl:versionInfo "draft-v0.95-20210617"@en .

#################################################################
#    Object Properties
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element
OpenPVSignal:Free_text_reporting_element rdf:type owl:ObjectProperty .


###  http://purl.org/mp/publishedBy
mp:publishedBy rdf:type owl:ObjectProperty .


###  http://purl.org/mp/references
mp:references rdf:type owl:ObjectProperty .


###  http://purl.org/mp/supportedByData
mp:supportedByData rdf:type owl:ObjectProperty .


#################################################################
#    Classes
#################################################################

###  http://www.w3.org/ns/prov#Organization
prov:Organization rdf:type owl:Class .


#################################################################
#    Individuals
#################################################################

###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Antipsychotics_and_dystonia
:Antipsychotics_and_dystonia rdf:type owl:NamedIndividual ,
                                      OpenPVSignal:Warning_Information ;
                             OpenPVSignal:refers_to_adverse_effect :dystonia ;
                             OpenPVSignal:refers_to_class :antipsychotics ;
                             mp:references :Ref.9 ;
                             OpenPVSignal:has_content "Antipsychotics are known to cause dystonia, although trismus is not specifically labelled as an adverse reaction except for ziprasidone.9" ;
                             rdfs:label "Antipsychotics and dystonia" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#AttentionDeficitHyperactivityDisorder
:AttentionDeficitHyperactivityDisorder rdf:type owl:NamedIndividual ,
                                                OpenPVSignal:Indication ;
                                       OpenPVSignal:has_ICD_code "F90" ;
                                       OpenPVSignal:has_MedDRA_code 10083622 ;
                                       OpenPVSignal:has_MedDRA_prefered_term "Attention deficit hyperactivity disorder" ;
                                       rdfs:label "attention deficit hyperactivity disorder" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Discussion
:Discussion rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Discussion ;
            mp:references :Ref.12 ,
                          :Ref.13 ,
                          :Ref.14 ,
                          :Ref.15 ,
                          :Ref.5 ;
            OpenPVSignal:has_content """The mechanism behind trismus reported in the cases was thought to be a dystonic reaction induced by the dopamine-altering mechanism of methylphenidate. A VigiBase search on 13 August 2018 revealed that there were 213 reports of methylphenidate and dystonias (MedDRA High Level Term, HLT). Among these, only 74 cases reported concomitant treatment with antipsychotics (aripiprazole, olanzapine, quetiapine, risperidone and/or ziprasidone) which are known to cause dystonia. We restricted the in-depth assessment to cases with reports of jaw-related events because we thought patients would benefit from knowing about these specific reactions as these can be distressing and painful. The product information does not describe dystonia as an adverse reaction, but it could be argued its symptoms are covered by the mention of muscle tightness, spasms, and cramps, while lacking a description of specific body parts affected.
The mechanism behind dystonia is unclear but it seems to be caused by an abnormal dopaminergic activity involving the basal ganglia. Two contrasting hypotheses have been proposed: 1) dopaminergic hypofunction within basal ganglia leading to overactivity of the cholinergic system, and 2) hyperactivity of dopaminergic pathways.5 Therefore, any drug that alters dopamine signalling, whether by inhibiting it (such as for antipsychotics), or by increasing it, could in theory cause dystonic reactions. So, it could be hypothesized that methylphenidate can cause dystonic reactions such as trismus, through its stimulatory effect on dopamine signalling (inhibits reuptake and facilitates release of monoamines into synaptic cleft).
For six cases there was some doubt about whether
 
 	the patients experienced the reported trismus or if they experienced dyskinetic reactions. Dyskinesia is labelled for methylphenidate. The narrative in these cases described reactions such as “jaw moving back and forth”, “constantly drops jaw and mouth”, “jaw twitching”, “jaw movements” and “motorial agitation” reflecting a possible coding issue.
Three patients in this assessment recovered from trismus without changing the methylphenidate treatment. These observations might somewhat weaken the hypothesis that methylphenidate may induce trismus.
However, the literature reports of dystonia associated with methylphenidate withdrawal12-15 suggest that methylphenidate could cause dystonic reactions by disrupting the dopamine balance. In these cases, the patients were treated with both methylphenidate which stimulates dopamine action, and with antipsychotics which block dopamine action and seemed to have reached a balance in dopamine levels. They only experienced dystonic reactions when methylphenidate was withdrawn, that is when the dopamine balance was disrupted.
Having trismus can be painful and distressing for the patient. For example, in one case the patient could not sleep because of it. In another case, the patient was unable to move his jaw or close his mouth. He was taken to the emergency room and prescribed diphenhydramine to treat it, but his jaw would still lock up. Therefore, being able to connect that trismus could be an adverse effect of methylphenidate could play a role in deciding whether to start or continue with the treatment, especially if it is a recurring problem.""" ;
            rdfs:label "Discussion" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Dyskinesia_pathology
:Dyskinesia_pathology rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Free_text_reporting_element ;
                      OpenPVSignal:refers_to_adverse_effect :dyskinesia ;
                      mp:references :Ref.5 ,
                                    :Ref.6 ;
                      OpenPVSignal:has_content "Dyskinesia, on the other hand is characterized by abnormal, involuntary, repetitive and persistent movements affecting the mouth and face, extremities and the trunk.6 Tardive dyskinesia can develop after treatment with dopamine receptor-blocking agents, usually one month after starting treatment.5 Symptoms are not painful but can still be debilitating." ;
                      rdfs:label "Dyskinesia pathophysiology" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Dystonia_pathology
:Dystonia_pathology rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Free_text_reporting_element ;
                    OpenPVSignal:refers_to_adverse_effect :dystonia ;
                    mp:references :Ref.5 ;
                    OpenPVSignal:has_content "Dystonia is characterized by “muscular contractions or spasms that result in abnormal fixed postures or positions of the jaw, neck, shoulders, trunk, and extremities”.5 It can also result in twisting and repetitive movements. The symptoms are associated with pain and distress, and can cause difficulty with walking, speech, head turning, and swallowing." ;
                    rdfs:label "Dystonia pathophysiology" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#IC025_for_methylphenidate_and_trismus
:IC025_for_methylphenidate_and_trismus rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component__025_(IC025)> ;
                                       OpenPVSignal:refers_to_adverse_effect :trismus ;
                                       OpenPVSignal:refers_to_drug :methylphenidate ;
                                       OpenPVSignal:has_value 1.04 ;
                                       OpenPVSignal:refers_to_number_of_reports 27 ;
                                       rdfs:label "IC025 for methylphenidate and trismus" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Introduction_content
:Introduction_content rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Introduction ;
                      mp:references :Ref.1 ,
                                    :Ref.2 ,
                                    :Ref.3 ,
                                    :Ref.4 ,
                                    :Ref.5 ,
                                    :Ref.6 ,
                                    :Ref.7 ;
                      OpenPVSignal:has_content """In April 2018, during a screening of VigiBase, the WHO global database of individual case safety reports, focusing on patient reports, the combination of methylphenidate and muscle tightness was identified as needing further in-depth assessment. Several cases described jaw tightness, and further exploration of VigiBase revealed many cases of trismus (lockjaw).
Methylphenidate is a centrally acting sympathomimetic indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).1 The US Food and Drug Administration (FDA) first approved methylphenidate back in 1955, for various psychological disorders, and in the 1970s it was introduced to treat ADHD.2 Even though the drug has been on the market for a long time, the mechanism by which it exerts its therapeutic effect is still not clearly established. It is thought to facilitate the action of dopamine and norepinephrine through three mechanisms: 1) inhibition of reuptake, 2) facilitation of release into the synaptic cleft, and, 3) inhibition of the catabolic activity of monoamine oxidase.3
 
Trismus, or lockjaw, is the inability to open the mouth, usually because of muscle spasms. Causes include physical trauma, oral/dental surgery, infections, and temporomandibular joint disease (e.g. rheumatoid arthritis). Trismus can also be part of a drug-induced dystonic reaction. Antipsychotics (e.g. risperidone, aripiprazole) and antiemetics (e.g. metoclopramide) are known to cause dystonia, and it seems to be caused by an abnormal dopaminergic activity involving the basal ganglia.4
Dystonia is characterized by “muscular contractions or spasms that result in abnormal fixed postures or positions of the jaw, neck, shoulders, trunk, and extremities”.5 It can also result in twisting and repetitive movements. The symptoms are associated with pain and distress, and can cause difficulty with walking, speech, head turning, and swallowing. Dyskinesia, on the other hand is characterized by abnormal, involuntary, repetitive and persistent movements affecting the mouth and face, extremities and the trunk.6 Tardive dyskinesia can develop after treatment with dopamine receptor-blocking agents, usually one month after starting treatment.5 Symptoms are not painful but can still be debilitating.
Trismus, or any other jaw-related event, is not labelled for methylphenidate, but muscle tightness, muscle spasms, muscle twitching and muscle cramps are described.1,7 The labelled events are general and may not be specific enough for the patient to be able to connect them to trismus.
Hence, the possible association of methylphenidate and trismus was investigated further.""" ;
                      rdfs:label "Introduction content" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Jaw_joint_rigid_state_of
:Jaw_joint_rigid_state_of rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Adverse_Effect ;
                          OpenPVSignal:has_MedDRA_code 10023151 ;
                          OpenPVSignal:has_MedDRA_prefered_term "Jaw joint rigid state of" ;
                          rdfs:label "jaw joint rigid state of" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Labelling_for_methylphenidate
:Labelling_for_methylphenidate rdf:type owl:NamedIndividual ,
                                        obo:OAE_0001197 ,
                                        OpenPVSignal:Structured_Product_Labels_information ,
                                        OpenPVSignal:Warning_Information ;
                               OpenPVSignal:refers_to_adverse_effect :muscleSpasms ,
                                                                     :muscleTwitching ,
                                                                     :muscle_cramps ,
                                                                     :muscle_tightness ;
                               OpenPVSignal:refers_to_drug :methylphenidate ;
                               mp:references :Ref.1 ,
                                             :Ref.7 ;
                               OpenPVSignal:has_content "Trismus (or any other jaw-related adverse reaction) is not described in the UK Summary of Product Characteristics (SmPC) or in the US FDA label for methylphenidate.1,7 However, muscle tightness, muscle spasms, muscle twitching and muscle cramps are all described although they don’t refer specifically to the jaw or mouth." ,
                                                        "Trismus, or any other jaw-related event, is not labelled for methylphenidate, but muscle tightness, muscle spasms, muscle twitching and muscle cramps are described.1,7" ;
                               rdfs:label "Labelling for methylphenidate" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Lareb_report
:Lareb_report rdf:type owl:NamedIndividual ,
                       obo:OAE_0001197 ;
              OpenPVSignal:refers_to_adverse_effect :trismus ;
              OpenPVSignal:refers_to_drug :dexamfetamine ,
                                          :methylphenidate ;
              mp:references :Ref.11 ,
                            :Ref.8 ;
              OpenPVSignal:has_content "In 2012, the Netherlands Pharmacovigilance Centre Lareb published a signal describing the association between trismus and the use of methylphenidate and dexamphetamine.8 At the time of the assessment, their database contained seven cases of jaw cramp/trismus associated with methylphenidate use (all of which are included in this assessment) and two cases of trismus associated with dexamphetamine use. Trismus and methylphenidate was disproportionately reported in the Lareb database, in the WHO global database and in the Eudravigilance database. In 2013, Prescrire wrote about methylphenidate and trismus, referring to Lareb’s signal, and argued that trismus should be recognised as an adverse reaction in patients exposed to methylphenidate.11" ;
              rdfs:label "Lareb report" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Literature_and_Labelling
:Literature_and_Labelling rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Literature_information ;
                          mp:references :Ref.1 ,
                                        :Ref.10 ,
                                        :Ref.11 ,
                                        :Ref.12 ,
                                        :Ref.13 ,
                                        :Ref.14 ,
                                        :Ref.15 ,
                                        :Ref.16 ,
                                        :Ref.17 ,
                                        :Ref.7 ,
                                        :Ref.8 ;
                          OpenPVSignal:has_content """Trismus (or any other jaw-related adverse reaction) is not described in the UK Summary of Product Characteristics (SmPC) or in the US FDA label for methylphenidate.1,7 However, muscle tightness, muscle spasms, muscle twitching and muscle cramps are all described although they don’t refer specifically to the jaw or mouth.
In the UK Patient Information Leaflet (PIL), the following adverse reactions are described: “muscle spasms which you cannot control affecting your eyes, head, neck, body and nervous system”, “muscle tightness, muscle cramps”, “muscle pain, muscle twitching”.10
Jaw-specific reactions are not covered in the leaflet, although “uncontrolled speech and body movements” and “clenching or grinding your teeth” are.
In 2012, the Netherlands Pharmacovigilance Centre Lareb published a signal describing the association between trismus and the use of methylphenidate and dexamphetamine.8 At the time of the assessment, their database contained seven cases of jaw cramp/trismus associated with methylphenidate use (all of which are included in this assessment) and two cases of trismus associated with dexamphetamine use. Trismus and methylphenidate was disproportionately reported in the Lareb database, in the WHO global database and in the Eudravigilance database. In 2013, Prescrire wrote about methylphenidate and trismus, referring to Lareb’s signal, and argued that trismus should be recognised as an adverse reaction in patients exposed to methylphenidate.11
There are several published case reports of methylphenidate-associated dystonic reactions in connection to concomitant use of antipsychotic drugs, including cases of dystonia occurring after abrupt methylphenidate withdrawal.12-15 In our case
 
series only five cases have concomitant antipsychotic medications, of which two are literature reports.12,13
However, there are few literature cases of dystonia associated with methylphenidate-only treatment. Tekin et al describe a 15-year-old female who experienced involuntary extensor muscular contraction of her right hand and wrist together with tension and severe pain, nine days after taking 27 mg of modified-release methylphenidate.16 She was diagnosed with acute focal dystonic reaction which subsided after diazepam administration. A few years prior, the patient had experienced muscular contraction in her foot when she took immediate-release methylphenidate, which disappeared when the drug was stopped. In another case, a 7-year-old female diagnosed with ADHD was prescribed 5 mg of immediate-release methylphenidate twice daily.17 After her third dose, she developed dystonic movements characterized by turning the neck sideways and twisted facial muscles.""" ;
                          rdfs:label "Literature and Labelling" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Magnus_Ekelo
:Magnus_Ekelo rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Author ;
              OpenPVSignal:has_affiliation "Uppsala Monitoring Centre" ;
              OpenPVSignal:has_first_name "Magnus" ;
              OpenPVSignal:has_last_name "Ekelo" ;
              rdfs:label "Magnus Ekelo" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Marian_Attalla
:Marian_Attalla rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Author ;
                OpenPVSignal:has_affiliation "Uppsala Monitoring Centre" ;
                OpenPVSignal:has_first_name "Marian" ;
                OpenPVSignal:has_last_name "Attalla" ;
                rdfs:label "Marian Attalla" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Mechanism_of_Methylphenydate
:Mechanism_of_Methylphenydate rdf:type owl:NamedIndividual ,
                                       OpenPVSignal:Mechanism ;
                              mp:references :Ref.1 ,
                                            :Ref.2 ,
                                            :Ref.3 ;
                              OpenPVSignal:has_content "Methylphenidate is a centrally acting sympathomimetic indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). The US Food and Drug Administration (FDA) first approved methylphenidate back in 1955, for various psychological disorders, and in the 1970s it was introduced to treat ADHD.2 Even though the drug has been on the market for a long time, the mechanism by which it exerts its therapeutic effect is still not clearly established. It is thought to facilitate the action of dopamine and norepinephrine through three mechanisms: 1) inhibition of reuptake, 2) facilitation of release into the synaptic cleft, and, 3) inhibition of the catabolic activity of monoamine oxidase." ;
                              rdfs:label "Mechanism of Methylphenydate" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Mechanism_of_dystonia
:Mechanism_of_dystonia rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Adverse_Effect_Mechanism ;
                       OpenPVSignal:refers_to_adverse_effect :dystonia ;
                       mp:references :Ref.5 ;
                       OpenPVSignal:has_content "The mechanism behind dystonia is unclear but it seems to be caused by an abnormal dopaminergic activity involving the basal ganglia. Two contrasting hypotheses have been proposed: 1) dopaminergic hypofunction within basal ganglia leading to overactivity of the cholinergic system, and 2) hyperactivity of dopaminergic pathways.5 Therefore, any drug that alters dopamine signalling, whether by inhibiting it (such as for antipsychotics), or by increasing it, could in theory cause dystonic reactions. So, it could be hypothesized that methylphenidate can cause dystonic reactions such as trismus, through its stimulatory effect on dopamine signalling (inhibits reuptake and facilitates release of monoamines into synaptic cleft)." ;
                       rdfs:label "Mechanism of dystonia" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Methylphenidate_and_dyskinesia
:Methylphenidate_and_dyskinesia rdf:type owl:NamedIndividual ,
                                         OpenPVSignal:Structured_Product_Labels_information ,
                                         OpenPVSignal:Warning_Information ;
                                OpenPVSignal:refers_to_adverse_effect :dyskinesia ;
                                OpenPVSignal:refers_to_drug :methylphenidate ;
                                rdfs:label "Methylphenidate and dyskinesia" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Methylphenidate_and_lockjaw
:Methylphenidate_and_lockjaw rdf:type owl:NamedIndividual ,
                                      OpenPVSignal:Pharmacovigilance_Signal_Report ;
                             OpenPVSignal:refers_to_author :Magnus_Ekelo ,
                                                           :Marian_Attalla ;
                             OpenPVSignal:refers_to_signal :pvSignal ;
                             mp:publishedBy :Uppsala_Monitoring_Centre ;
                             OpenPVSignal:has_creation_date "01/08/2019" ;
                             OpenPVSignal:has_overall_conclusion "causal association" ;
                             rdfs:label "Methylphenidate and lockjaw" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Proposed_mechanism_of_dystonic_reaction
:Proposed_mechanism_of_dystonic_reaction rdf:type owl:NamedIndividual ,
                                                  OpenPVSignal:Adverse_Effect_Mechanism ;
                                         OpenPVSignal:refers_to_adverse_effect :dystonia ;
                                         mp:references :Ref.12 ,
                                                       :Ref.13 ,
                                                       :Ref.14 ,
                                                       :Ref.15 ;
                                         OpenPVSignal:has_content "However, the literature reports of dystonia associated with methylphenidate withdrawal12-15 suggest that methylphenidate could cause dystonic reactions by disrupting the dopamine balance. In these cases, the patients were treated with both methylphenidate which stimulates dopamine action, and with antipsychotics which block dopamine action and seemed to have reached a balance in dopamine levels. They only experienced dystonic reactions when methylphenidate was withdrawn, that is when the dopamine balance was disrupted." ;
                                         rdfs:label "Proposed mechanism of dystonic reaction" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.1
:Ref.1 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "electronic Medicines Compendium: Summary of Product Characteristics for methylphenidate (Concerta®). Available from: https://www.medicines.org.uk/emc/product/68 72/smpc. Accessed: 10 July 2018." ;
       rdfs:label "Ref.1" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.10
:Ref.10 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Bibliographic_reference ;
        OpenPVSignal:has_content "Electronic Medicines Compendium: Patient Information Leaflet for methylphenidate (Concerta®). Available from: https://www.medicines.org.uk/emc/files/pil.687 2.pdf. Accessed: 10 July 2018." ;
        rdfs:label "Ref.10" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.11
:Ref.11 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Bibliographic_reference ;
        OpenPVSignal:has_content "Prescrire. Methylphenidate: trismus. Prescrire Int. 2013 Jul;22(140):185." ;
        rdfs:label "Ref.11" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.12
:Ref.12 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Bibliographic_reference ;
        OpenPVSignal:has_content "LeRiger M, Williams J, Duncan-Wiebe G, Shukry M. Acute masseter dystonia in a pediatric patient receiving aripiprazole and methylphenidate following induction of general anesthesia. Paediatr Anaesth. 2017 Aug;27(8):863-864." ;
        rdfs:label "Ref.12" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.13
:Ref.13 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Bibliographic_reference ;
        OpenPVSignal:has_content "McLaren JL, Cauble S, Barnett RJ. Aripiprazole induced acute dystonia after discontinuation of a stimulant medication. J Clin Psychopharmacol. 2010 Feb;30(1):77-8." ;
        rdfs:label "Ref.13" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.14
:Ref.14 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Bibliographic_reference ;
        OpenPVSignal:has_content "Grau-López L, Daigre C, Mercado N, Casas M, Roncero C. Dystonia in Methylphenidate Withdrawal: A Case Report. J Addict Med. 2017 Mar/Apr;11(2):154-156." ;
        rdfs:label "Ref.14" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.15
:Ref.15 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Bibliographic_reference ;
        OpenPVSignal:has_content "Párraga HC, Sherman BC. Acute Dystonia After Stimulant Discontinuation in 2 ADHD Children Receiving Aripiprazole. J Clin Psychopharmacol. 2015 Aug 1;35(4):480-1." ;
        rdfs:label "Ref.15" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.16
:Ref.16 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Bibliographic_reference ;
        OpenPVSignal:has_content "Tekin U, Soyata AZ, Oflaz S. Acute focal dystonic reaction after acute methylphenidate treatment in an adolescent patient. J Clin Psychopharmacol. 2015 Apr;35(2):209-11." ;
        rdfs:label "Ref.16" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.17
:Ref.17 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Bibliographic_reference ;
        OpenPVSignal:has_content "Uzun ME, Korkmaz MF, Ekici A, Kaymaz N. Methylphenidate induce acute dystonic reaction. Indian J Pediatr. 2018 Jul;85(7):577." ;
        rdfs:label "Ref.17" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.2
:Ref.2 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Gilman V. Ritalin. Chem Eng News. 2005;83(25)." ;
       rdfs:label "Ref.2" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.3
:Ref.3 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Solanto, MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res. 1998;94(1):127-152." ;
       rdfs:label "Ref.3" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.4
:Ref.4 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Scully C. Oral and maxillofacial medicine: the basis of diagnosis and treatment. 3rd ed. New York;Edinburgh: Churchill Livingstone/Elsevier; 2013." ;
       rdfs:label "Ref.4" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.5
:Ref.5 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Tisdale JE, Miller DA. Drug-induced diseases: prevention, detection, and management. 2nd ed. Bethesda: American Society of Health- System Pharmacists; 2010." ;
       rdfs:label "Ref.5" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.6
:Ref.6 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Merrill RM, Lyon JL, Matiaco PM. Tardive and spontaneous dyskinesia incidence in the general population. BMC Psychiatry. 2013;13:152." ;
       rdfs:label "Ref.6" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.7
:Ref.7 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "US Food and Drug Administration: Product label for methylphenidate (Concerta®). Available from: https://dailymed.nlm.nih.gov/dailymed/drugInf o.cfm?setid=1a88218c-5b18-4220-8f56- 526de1a276c-d&audience=consumer. Accessed: 10 July 2018." ;
       rdfs:label "Ref.7" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.8
:Ref.8 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Netherlands Pharmacovigilance Centre Lareb. Methylphenidate, dexamphetamine and trismus. 2012. Available from: https://databankws.lareb.nl/Downloads/KWB_2 012_4_methyl1.pdf. Accessed: 3 July 2018." ;
       rdfs:label "Ref.8" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Ref.9
:Ref.9 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "US Food and Drug Administration: Product label for ziprasidone. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInf o.cfm?setid=315e24 c2-2f8c-47d9-b1b1- ce006646098a&audience=consumer. Accessed: 13 August 2018." ;
       rdfs:label "Ref.9" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report1
:Report1 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:has_free_text_reporting_element :case_1_info ;
         OpenPVSignal:refers_to_adverse_effect :eyeDisorder ,
                                               :trismus ,
                                               :visionBlurred ;
         OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#5/M> ;
         OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
         OpenPVSignal:time_to_onset :TimeToOnset1 ;
         OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
         rdfs:label "Report 1" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report10
:Report10 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :feelingJittery ,
                                                :mouthSwelling ,
                                                :muscle_tightness ,
                                                :palpitations ,
                                                :swollenTongue ,
                                                :tightnessInJaw ,
                                                :trismus ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#60/M> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:time_to_onset :TimeToOnset10 ;
          OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
          OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
          rdfs:label "Report 10" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report11
:Report11 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :dyspnoea ,
                                                :insomnia ,
                                                :trismus ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#8/M> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:refers_to_secondary_suspect_drug :diphenhydramine ;
          OpenPVSignal:time_to_onset :TimeToOnset11 ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report 11" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report12
:Report12 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :case_info_12 ;
          OpenPVSignal:refers_to_adverse_effect :pain ,
                                                :swollenTongue ,
                                                :tongueSpasm ,
                                                :trismus ;
          OpenPVSignal:refers_to_concomitant_drug :bupropion ,
                                                  :ziprasidone ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#15/M> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:refers_to_secondary_suspect_drug :diphenhydramine ;
          OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
          rdfs:label "Report 12" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report13
:Report13 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :dyskinesia ,
                                                :eyeDisorder ,
                                                :gaitDisturbance ,
                                                :muscleTwitching ,
                                                :tongueDisorderCondition ,
                                                :trismus ;
          OpenPVSignal:refers_to_patient :patient_13 ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:time_to_onset :TimeToOnset13 ;
          OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
          OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
          rdfs:label "Report 13" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report14
:Report14 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :decreasedAppetite ,
                                                :dizziness ,
                                                :dystonia ,
                                                :trismus ,
                                                :weightDecreased ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#16/M> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:refers_to_secondary_suspect_drug :oxybateSodium ;
          rdfs:label "Report 14" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report15
:Report15 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :case_15_info ;
          OpenPVSignal:refers_to_adverse_effect :anxiety ,
                                                :clusterHeadache ,
                                                :dizziness ,
                                                :hyperhidrosis ,
                                                :hypertension ,
                                                :palpitations ,
                                                :therapeuticResponseUnexpected ,
                                                :tremor ,
                                                :trismus ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#42/M> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:time_to_onset :TimeToOnset15 ;
          OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
          rdfs:label "Report 15" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report16
:Report16 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :drugInteraction ,
                                                :hypertonia ,
                                                :trismus ;
          OpenPVSignal:refers_to_concomitant_drug :ethinylestradiol ,
                                                  :levonorgestrel ;
          OpenPVSignal:refers_to_interacting_drug :methylphenidate ,
                                                  :omeprazole ,
                                                  :paroxetine ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#30/F> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ,
                                                      :omeprazole ,
                                                      :paroxetine ;
          OpenPVSignal:time_to_onset :TimeToOnset16 ;
          OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
          OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
          rdfs:label "Report 16" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report17
:Report17 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :jawStiffness ,
                                                :jointStiffness ,
                                                :peripheralColdness ;
          OpenPVSignal:refers_to_patient :patient_17 ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:time_to_onset :TimeToOnset17 ;
          OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
          OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
          rdfs:label "Report 17" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report18
:Report18 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :aggression ,
                                                :anxiety ,
                                                :bruxism ,
                                                :coordinationAbnormal ,
                                                :crying ,
                                                :decreasedEyeContact ,
                                                :depressedMood ,
                                                :drugIneffective ,
                                                :dyskinesia ,
                                                :fatigue ,
                                                :homicidalIdeation ,
                                                :insomnia ,
                                                :irritability ,
                                                :moodAltered ,
                                                :oppositionalDefiantDisorder ,
                                                :poorQualitySleep ,
                                                :psychomotorHyperactivity ,
                                                :sleepDisorder ,
                                                :speechDisorder ,
                                                :streptococcalInfection ,
                                                :suicidalIdeation ,
                                                :trismus ,
                                                <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#sydenham'sChorea> ;
          OpenPVSignal:refers_to_patient :patient_18 ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:refers_to_secondary_suspect_drug :amfetamine ,
                                                        :aripiprazole ,
                                                        :atomoxetine ,
                                                        :carbamazepine ,
                                                        :chlorpromazine ,
                                                        :clonidine ,
                                                        :dexamfetamine ,
                                                        :iloperidone ,
                                                        :lisdexamfetamine ,
                                                        :lithium ,
                                                        :quetiapine ,
                                                        :valproicAcid ,
                                                        :ziprasidone ;
          rdfs:label "Report 18" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report19
:Report19 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :dyskinesia ,
                                                :trismus ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#24/M> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:time_to_onset :TimeToOnset19 ;
          OpenPVSignal:refers_to_dechallenge_outcome "negative - condition still applied" ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report 19" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report2
:Report2 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:has_free_text_reporting_element :case_2_info ;
         OpenPVSignal:refers_to_adverse_effect :jawDisorder ,
                                               :oromandibularDystonia ,
                                               :trismus ;
         OpenPVSignal:refers_to_concomitant_drug :clonidine ,
                                                 :fentanyl ,
                                                 :rocuronium ,
                                                 :sevoflurane ;
         OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#11/M> ;
         OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
         OpenPVSignal:refers_to_secondary_suspect_drug :aripiprazole ,
                                                       :propofol ;
         OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
         rdfs:label "Report 2" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report20
:Report20 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :case_20_info ;
          OpenPVSignal:refers_to_adverse_effect :extrapyramidalDisorder ,
                                                :trismus ;
          OpenPVSignal:refers_to_patient :patient_20 ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:time_to_onset :TimeToOnset20 ;
          OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
          OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
          OpenPVSignal:refers_to_rechallenge_outcome "positive rechallenge - condition appeared again" ;
          rdfs:label "Report 20" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report21
:Report21 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :bruxism ,
                                                :trismus ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#59/M> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 21" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report22
:Report22 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :case_22_info ;
          OpenPVSignal:refers_to_adverse_effect :trismus ;
          OpenPVSignal:refers_to_concomitant_drug :levonorgestrel ,
                                                  :propranolol ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#21/F> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:refers_to_secondary_suspect_drug :ethinylestradiol ;
          OpenPVSignal:time_to_onset :TimeToOnset22 ;
          OpenPVSignal:refers_to_outcome_after_action "recovery without drug withdrawal" ;
          rdfs:label "Report 22" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report23
:Report23 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :case_23_info ;
          OpenPVSignal:refers_to_adverse_effect :affectLability ,
                                                :aggression ,
                                                :dystonia ,
                                                :intentionalself-Injury ,
                                                :jointStiffness ,
                                                :muscleContracture ,
                                                :trismus ;
          OpenPVSignal:refers_to_concomitant_drug :clonidine ,
                                                  :lithium ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#11/-> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:refers_to_secondary_suspect_drug :aripiprazole ;
          OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
          rdfs:label "Report 23" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report24
:Report24 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :case_24_info ;
          OpenPVSignal:refers_to_adverse_effect :painInJaw ,
                                                :trismus ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#37/F> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:refers_to_secondary_suspect_drug :metoprolol ,
                                                        :sumatriptan ;
          OpenPVSignal:time_to_onset :TimeToOnset24 ;
          OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
          rdfs:label "Report 24" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report25
:Report25 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :trismus ;
          OpenPVSignal:refers_to_concomitant_drug :simvastatin ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#41/F> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:time_to_onset :TimeToOnset25 ;
          OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
          rdfs:label "Report 25" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report26
:Report26 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :hypersensitivity ,
                                                :trismus ;
          OpenPVSignal:refers_to_patient :patient_26 ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:refers_to_secondary_suspect_drug :cetirizine ,
                                                        :clonidine ,
                                                        :montelukast ,
                                                        :salbutamol ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report 26" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report27
:Report27 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :jawStiffness ,
                                                :jointStiffness ,
                                                :sleepDisorder ,
                                                <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#tourette'sDisorder> ;
          OpenPVSignal:refers_to_concomitant_drug :duloxetine ,
                                                  :metformin ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#55/F> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report 27" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report28
:Report28 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :dysphagia ,
                                                :logorrhoea ,
                                                :restlessness ,
                                                :trismus ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#8/F> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:time_to_onset :TimeToOnset28 ;
          OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
          OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
          rdfs:label "Report 28" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report29
:Report29 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :trismus ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#38/M> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:time_to_onset :TimeToOnset29 ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report 29" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report3
:Report3 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:has_free_text_reporting_element :case_3_info ;
         OpenPVSignal:refers_to_adverse_effect :decreasedAppetite ,
                                               :dryMouth ,
                                               :trismus ;
         OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#29/F> ;
         OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
         OpenPVSignal:refers_to_outcome_after_action "recovery without drug withdrawal" ;
         rdfs:label "Report 3" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report30
:Report30 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :facialSpasm ,
                                                :painInJaw ,
                                                :somnolence ,
                                                :tic ,
                                                :trismus ;
          OpenPVSignal:refers_to_patient :patient_30 ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:refers_to_secondary_suspect_drug :risperidone ;
          OpenPVSignal:refers_to_dechallenge_outcome "negative - condition still applied" ;
          rdfs:label "Report 30" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report31
:Report31 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :disturbanceInAttention ,
                                                :jawStiffness ,
                                                :jointStiffness ,
                                                :sleepDisorder ;
          OpenPVSignal:refers_to_patient :patient_31 ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 31" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report32
:Report32 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :trismus ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#7/M> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:refers_to_dechallenge_outcome "negative - condition still applied" ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report 32" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report33
:Report33 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :bloodPressureIncreased ,
                                                :dizziness ,
                                                :trismus ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#18/M> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:time_to_onset :TimeToOnset33 ;
          OpenPVSignal:refers_to_dechallenge_outcome "unknown" ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 33" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report34
:Report34 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :earPain ,
                                                :facialPain ,
                                                :gingivalDisorder ,
                                                :hyperacusis ,
                                                :hypoaesthesia ,
                                                :masticationDisorder ,
                                                :mobilityDecreased ,
                                                :muscleSpasms ,
                                                :myalgia ,
                                                :painInJaw ,
                                                :paraesthesia ,
                                                :trismus ;
          OpenPVSignal:refers_to_patient :patient_34 ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:refers_to_secondary_suspect_drug :amfetamine ,
                                                        :dexamfetamine ;
          rdfs:label "Report 34" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report35
:Report35 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :trismus ;
          OpenPVSignal:refers_to_patient :patient_35 ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:time_to_onset :TimeToOnset35 ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 35" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report36
:Report36 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :crying ,
                                                :neurologicalSymptom ,
                                                :torticollis ,
                                                :trismus ,
                                                :visionBlurred ;
          OpenPVSignal:refers_to_patient :patient_36 ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:time_to_onset :TimeToOnset36 ;
          OpenPVSignal:refers_to_dechallenge_outcome "unknown" ;
          rdfs:label "Report 36" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report37
:Report37 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :hyperhidrosis ,
                                                :jawStiffness ,
                                                :jointStiffness ,
                                                :tongueDisorderCondition ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#22/F> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:time_to_onset :TimeToOnset37 ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report 37" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report38
:Report38 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:has_free_text_reporting_element :case_38_info ;
          OpenPVSignal:refers_to_adverse_effect :decreasedAppetite ,
                                                :dryMouth ,
                                                :headache ,
                                                :muscle_tightness ,
                                                :sedation ,
                                                :tightnessOfJawMuscles ,
                                                :vertigo ;
          OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#35/F> ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:time_to_onset :TimeToOnset38 ;
          OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
          rdfs:label "Report 38" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report4
:Report4 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :depression ,
                                               :drugEffectIncomplete ,
                                               :irritability ,
                                               :jawStiffness ,
                                               :jointStiffness ,
                                               :musculoskeletalStiffness ,
                                               :tensionHeadache ;
         OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#-/F> ;
         OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
         OpenPVSignal:refers_to_outcome_after_action "unknown" ;
         rdfs:label "Report 4" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report5
:Report5 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :jawStiffness ,
                                               :jointStiffness ,
                                               :moodAltered ;
         OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#48/F> ;
         OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
         OpenPVSignal:time_to_onset :TimeToOnset5 ;
         OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
         OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
         rdfs:label "Report 5" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report6
:Report6 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :alopecia ,
                                               :hypoaesthesia ,
                                               :hypoaesthesiaOral ,
                                               :muscleSpasms ,
                                               :trismus ;
         OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#42/F> ;
         OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
         OpenPVSignal:time_to_onset :TimeToOnset6 ;
         OpenPVSignal:refers_to_dechallenge_outcome "negative - condition still applied" ;
         OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
         rdfs:label "Report 6" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report7
:Report7 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :chestDiscomfort ,
                                               :hypoaesthesia ,
                                               :muscle_tightness ,
                                               :tachycardia ,
                                               :tightnessOfJawMuscles ;
         OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#14/M> ;
         OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
         rdfs:label "Report 7" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report8
:Report8 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :fingerDeformity ,
                                               :muscle_tightness ,
                                               :tightnessOfJawMuscles ;
         OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#40/F> ;
         OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
         OpenPVSignal:refers_to_dechallenge_outcome "unknown" ;
         OpenPVSignal:refers_to_outcome_after_action "unknown" ;
         rdfs:label "Report 8" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Report9
:Report9 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :bruxism ,
                                               :eatingDisorder ,
                                               :tongueBiting ,
                                               :trismus ;
         OpenPVSignal:refers_to_patient <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#6/M> ;
         OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
         OpenPVSignal:time_to_onset :TimeToOnset9 ;
         OpenPVSignal:refers_to_outcome_after_action "unknown" ;
         OpenPVSignal:refers_to_partial_dechallenge_outcome "unknown" ;
         rdfs:label "Report 9" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Reports_in_VigiBase
:Reports_in_VigiBase rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Free_text_reporting_element ;
                     mp:references :Ref.8 ,
                                   :Ref.9 ;
                     OpenPVSignal:has_content """The association of methylphenidate and trismus is disproportionately over-reported compared to the overall reporting rate in VigiBase (IC025: 1.04). A total of 27 cases was observed, compared to the expected 8.3 (2 May 2018).
Cases which reported the MedDRA preferred term (PT) “trismus” or any of the lowest level terms (LLTs) “jaw joint rigid state of”, “jaw stiffness”, “tightness in jaw” or “tightness of jaw muscles”, were included in the assessment (see table 2 for which search terms were applied, displayed in the context of the MedDRA hierarchy).
The 44 cases retrieved from VigiBase had been entered between 1 November 2000 and 2 May 2018. Six suspected duplicate reports were excluded leaving 38 cases for analysis, of which 29 had been coded with trismus. The characteristics of the case series are summarized in Table 1. For more details on the individual cases, please refer to Table 3. Cases which reported oromandibular dystonia (PT) were reviewed, but since they concerned events quite different from trismus such as lingual dystonia (affecting the tongue), they were not included in our analysis.
Methylphenidate was the only suspected drug in 27 cases (of which three cases reported other concomitant drugs). The drug was withdrawn in 14 cases, the dose was reduced in one, the dose was
 
increased in one, the dose was not changed in five, and the action taken with the drug was unknown in 13 cases. For the four remaining cases, trismus occurred upon withdrawal or dose reduction of methylphenidate (the cases are described further down). Upon dechallenge or dose reduction, the reaction abated in eight cases, no effect was observed in four cases and in three cases the outcome was unknown. In seven of the eight cases of positive dechallenge, methylphenidate was the only suspect drug, with no other concomitants reported. In one case (20), a positive rechallenge was reported. The case describes a 40-year-old female who experienced extrapyramidal symptoms consisting of involuntary movement of the tongue and trismus 30 minutes after methylphenidate administration. The drug was withdrawn, and the patient recovered.
The patient was then treated with methylphenidate slow-release and the symptoms were reported to be less severe. The case was first described in a signal published by the Netherlands Pharmacovigilance Centre Lareb.8
In three cases, trismus resolved spontaneously without changing the methylphenidate treatment. One case (3) concerned a 29-year-old female who experienced one episode of trismus after increasing the methylphenidate dose from 30 to 40 mg. The adverse event resolved spontaneously, and the patient did not experience similar events later. No other concomitant drugs were reported. In another case (22), a 21-year-old female experienced trismus two days after administration of methylphenidate. The patient was reported to be recovering without changing the drug treatment.
She also used oestrogen with levonorgestrel (treatment with propranolol was also reported which started after trismus occurred). The third case (38) describes a 35-year-old female experiencing tightness of jaw muscles within a month after starting methylphenidate treatment which she recovered from without changing the administration of methylphenidate. Concomitant treatment with antipsychotics (aripiprazole, risperidone and/or ziprasidone) was reported in five cases and were reported as suspected in four of the cases. Antipsychotics are known to cause dystonia, although trismus is not specifically labelled as an adverse reaction except for ziprasidone.9 In three of these cases (2, 12, 23), onset of trismus followed abrupt discontinuation of methylphenidate whilst on concomitant treatment with antipsychotic drugs. In case 12, diphenhydramine was also withdrawn.
In another case (24) the patient was not treated with antipsychotics but still experienced trismus after a rapid decrease in the methylphenidate dose. The patient had used methylphenidate for one year and was normally treated with 80-120 mg/day. On the same day as she took only 20 mg, she developed trismus and jaw pain. The patient was also taking metoprolol and sumatriptan for migraine, both reported as suspected.""" ;
                     rdfs:label "Reports in VigiBase" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Summary_content
:Summary_content rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Summary ;
                 OpenPVSignal:has_content """Methylphenidate and trismus (lockjaw) was identified as a potential signal in a screening of VigiBase, the WHO global database of individual case safety reports, focusing on patient reports. The association is disproportionately over-reported compared to the overall rate in VigiBase with 27 observed cases, compared to the expected 8.3 (review of VigiBase on 2 May 2018). All cases which reported any of the terms “trismus”, “jaw stiffness”, “jaw joint rigid state of”, “tightness in jaw” or “tightness of jaw muscles”, were included in this assessment. In total, 38 reports were analysed.
Overall, the cases support an association between
methylphenidate and trismus, with the majority reporting methylphenidate as the only suspect drug and with eight cases reporting a positive dechallenge, of which one also reported a positive rechallenge. In addition, the dopamine-altering effect of methylphenidate provides a plausible mechanism behind trismus, which in these cases was thought to be a dystonic reaction. Trismus or lockjaw is not labelled for methylphenidate in either the Summary of Product Characteristics or the Patient Information Leaflet. However, the similar terms muscle tightness, muscle spasms, muscle twitching and muscle cramps are described.
Nonetheless, for patients, it might not be obvious
enough from these terms that jaw-related reactions might occur, and therefore they could benefit from more clarity as that might assist them in deciding to start or continue their treatment.""" ;
                 rdfs:label "Summary content" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Tekin_et_al_report
:Tekin_et_al_report rdf:type owl:NamedIndividual ,
                             obo:OAE_0001197 ;
                    OpenPVSignal:refers_to_adverse_effect :dystonia ;
                    OpenPVSignal:refers_to_drug :methylphenidate ;
                    mp:references :Ref.16 ;
                    OpenPVSignal:has_content "Tekin et al describe a 15-year-old female who experienced involuntary extensor muscular contraction of her right hand and wrist together with tension and severe pain, nine days after taking 27 mg of modified-release methylphenidate.16 She was diagnosed with acute focal dystonic reaction which subsided after diazepam administration. A few years prior, the patient had experienced muscular contraction in her foot when she took immediate-release methylphenidate, which disappeared when the drug was stopped." ;
                    rdfs:label "Tekin et al report" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset1
:TimeToOnset1 rdf:type owl:NamedIndividual ,
                       <http://www.w3.org/2006/time#DurationDescription> ;
              OpenPVSignal:has_content "Within 1 month after starting treatment but within 1 day after dose increase (from 18 to 27 mg)" ;
              <http://www.w3.org/2006/time#nominalPosition> "month" ;
              <http://www.w3.org/2006/time#numericPosition> 1 ;
              rdfs:label "Time to onset 1" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset10
:TimeToOnset10 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://www.w3.org/2006/time#nominalPosition> "minutes" ;
               <http://www.w3.org/2006/time#numericPosition> 30 ;
               rdfs:label "Time to onset 10" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset11
:TimeToOnset11 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://www.w3.org/2006/time#nominalPosition> "hours" ;
               <http://www.w3.org/2006/time#numericPosition> 4 ;
               rdfs:label "Time to onset 11" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset13
:TimeToOnset13 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 1 ;
               rdfs:label "Time to onset 13" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset15
:TimeToOnset15 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 1 ;
               rdfs:label "Time to onset 15" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset16
:TimeToOnset16 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               OpenPVSignal:has_content "1 hour" ;
               <http://www.w3.org/2006/time#nominalPosition> "hours" ;
               <http://www.w3.org/2006/time#numericPosition> 1 ;
               rdfs:label "Time to onset 16" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset17
:TimeToOnset17 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               OpenPVSignal:has_content "“days”" ;
               rdfs:label "Time to onset 17" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset19
:TimeToOnset19 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://www.w3.org/2006/time#nominalPosition> "months" ;
               <http://www.w3.org/2006/time#numericPosition> 4 ;
               rdfs:label "Time to onset 19" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset20
:TimeToOnset20 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://www.w3.org/2006/time#nominalPosition> "minutes" ;
               <http://www.w3.org/2006/time#numericPosition> 30 ;
               rdfs:label "Time to onset 20" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset22
:TimeToOnset22 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 2 ;
               rdfs:label "Time to onset 22" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset24
:TimeToOnset24 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               OpenPVSignal:has_content "1 year since starting treatment with methylphenidate but on same day as dose was reduced" ;
               <http://www.w3.org/2006/time#nominalPosition> "years" ;
               <http://www.w3.org/2006/time#numericPosition> 1 ;
               rdfs:label "Time to onset 24" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset25
:TimeToOnset25 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://www.w3.org/2006/time#nominalPosition> "months" ;
               <http://www.w3.org/2006/time#numericPosition> 10 ;
               rdfs:label "Time to onset 25" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset28
:TimeToOnset28 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://www.w3.org/2006/time#nominalPosition> "hours" ;
               <http://www.w3.org/2006/time#numericPosition> 8 ;
               rdfs:label "Time to onset 28" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset29
:TimeToOnset29 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 35 ;
               rdfs:label "Time to onset 29" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset33
:TimeToOnset33 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 7 ;
               rdfs:label "Time to onset 33" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset35
:TimeToOnset35 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               OpenPVSignal:has_content "“years”" ;
               rdfs:label "Time to onset 35" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset36
:TimeToOnset36 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 1 ;
               rdfs:label "Time to onset 36" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset37
:TimeToOnset37 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://www.w3.org/2006/time#nominalPosition> "minutes" ;
               <http://www.w3.org/2006/time#numericPosition> 31 ;
               rdfs:label "Time to onset 37" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset38
:TimeToOnset38 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               OpenPVSignal:has_content "Same month as starting treatment (exact unknown)" ;
               rdfs:label "Time to onset 38" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset5
:TimeToOnset5 rdf:type owl:NamedIndividual ,
                       <http://www.w3.org/2006/time#DurationDescription> ;
              <http://www.w3.org/2006/time#nominalPosition> "months" ;
              <http://www.w3.org/2006/time#numericPosition> 11.7 ;
              rdfs:label "Time to onset 5" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset6
:TimeToOnset6 rdf:type owl:NamedIndividual ,
                       <http://www.w3.org/2006/time#DurationDescription> ;
              <http://www.w3.org/2006/time#nominalPosition> "days" ;
              <http://www.w3.org/2006/time#numericPosition> 3 ;
              rdfs:label "Time to onset 6" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#TimeToOnset9
:TimeToOnset9 rdf:type owl:NamedIndividual ,
                       <http://www.w3.org/2006/time#DurationDescription> ;
              OpenPVSignal:has_content "0 days Dose given in the morning before patient went to school and developed adverse reaction in the afternoon" ;
              <http://www.w3.org/2006/time#nominalPosition> "days" ;
              <http://www.w3.org/2006/time#numericPosition> 0 ;
              rdfs:label "Time to onset 9" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Time_to_onset_info
:Time_to_onset_info rdf:type owl:NamedIndividual ,
                             <http://www.w3.org/2006/time#DurationDescription> ;
                    OpenPVSignal:has_content """Range: 30 minutes – 1 year 
TTO reported in 22 cases. TTO was within one day in ten of these cases. 
In four cases trismus occurred after abrupt withdrawal (3) or dose reduction (1) of methylphenidate""" ;
                    rdfs:label "Time to onset info" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#UK_PIL
:UK_PIL rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Structured_Product_Labels_information ;
        OpenPVSignal:refers_to_adverse_effect :muscleSpasms ,
                                              :muscleTwitching ,
                                              :muscle_cramps ,
                                              :muscle_pain ,
                                              :muscle_tightness ,
                                              :teeth_clenching ,
                                              :teeth_grinding ;
        OpenPVSignal:refers_to_drug :methylphenidate ;
        mp:references :Ref.10 ;
        OpenPVSignal:has_content "In the UK Patient Information Leaflet (PIL), the following adverse reactions are described: “muscle spasms which you cannot control affecting your eyes, head, neck, body and nervous system”, “muscle tightness, muscle cramps”, “muscle pain, muscle twitching”.10 Jaw-specific reactions are not covered in the leaflet, although “uncontrolled speech and body movements” and “clenching or grinding your teeth” are." ;
        rdfs:label "UK PIL" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Uppsala_Monitoring_Centre
:Uppsala_Monitoring_Centre rdf:type owl:NamedIndividual ,
                                    prov:Organization ;
                           rdfs:label "Uppsala Monitoring Centre" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Uzun_et_al_report
:Uzun_et_al_report rdf:type owl:NamedIndividual ,
                            obo:OAE_0001197 ;
                   OpenPVSignal:refers_to_adverse_effect :dystonia ;
                   OpenPVSignal:refers_to_drug :methylphenidate ;
                   mp:references :Ref.17 ;
                   OpenPVSignal:has_content "In another case, a 7-year-old female diagnosed with ADHD was prescribed 5 mg of immediate-release methylphenidate twice daily.17 After her third dose, she developed dystonic movements characterized by turning the neck sideways and twisted facial muscles." ;
                   rdfs:label "Uzun et al report" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#affectLability
:affectLability rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "R4586" ;
                OpenPVSignal:has_MedDRA_code 10054196 ;
                OpenPVSignal:has_MedDRA_prefered_term "Affect lability" ;
                rdfs:label "affect lability" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#aggression
:aggression rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "G245" ;
            OpenPVSignal:has_MedDRA_code 10001488 ;
            OpenPVSignal:has_MedDRA_prefered_term "Aggression" ;
            rdfs:label "aggression" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#alopecia
:alopecia rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "L659" ;
          OpenPVSignal:has_MedDRA_code 10001760 ;
          OpenPVSignal:has_MedDRA_prefered_term "Alopecia" ;
          rdfs:label "alopecia" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#amfetamine
:amfetamine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N06BA01 " ;
            rdfs:label "amfetamine" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#antipsychotics
:antipsychotics rdf:type owl:NamedIndividual ,
                         OpenPVSignal:DrugClass ;
                OpenPVSignal:has_ATC_code "N05A" ;
                rdfs:label "antipsychotics" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#anxiety
:anxiety rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "F419" ;
         OpenPVSignal:has_MedDRA_code 10002855 ;
         OpenPVSignal:has_MedDRA_prefered_term "Anxiety" ;
         rdfs:label "anxiety" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#aripiprazole
:aripiprazole rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "N05AX12" ;
              rdfs:label "aripiprazole" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#atomoxetine
:atomoxetine rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "N05AX12" ;
             rdfs:label "atomoxetine" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#bloodPressureIncreased
:bloodPressureIncreased rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Adverse_Effect ;
                        OpenPVSignal:has_ICD_code "R454" ;
                        OpenPVSignal:has_MedDRA_code 10005750 ;
                        OpenPVSignal:has_MedDRA_prefered_term "Blood pressure increased" ;
                        rdfs:label "blood pressure increased" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#bruxism
:bruxism rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "G255" ;
         OpenPVSignal:has_MedDRA_code 10006514 ;
         OpenPVSignal:has_MedDRA_prefered_term "Bruxism" ;
         rdfs:label "bruxism" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#bupropion
:bupropion rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "A08AA62" ,
                                     "N06BA09" ;
           rdfs:label "bupropion" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#carbamazepine
:carbamazepine rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "N06AX12" ;
               rdfs:label "carbamazepine" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#case_15_info
:case_15_info rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Case_Report_Information ;
              OpenPVSignal:has_content "Dose not changed/Reaction abated Comment: the report narrative states that the methylphenidate dose was reduced from 108 to 90 mg after one year of treatment and withdrawn completely after four years. reports. However, it is unclear whether the patient recovered from jaw cramps before or after the dose reduction/withdrawal." ;
              rdfs:label "case 15 info" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#case_1_info
:case_1_info rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Case_Report_Information ;
             OpenPVSignal:has_content "Dose increased/No effect observed It is unclear if the dose increase refers to the increase from 18 to 27 mg which occurred before reaction onset." ;
             rdfs:label "case 1 info" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#case_20_info
:case_20_info rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Case_Report_Information ;
              mp:references :Ref.8 ;
              OpenPVSignal:has_content "In one case (20), a positive rechallenge was reported. The case describes a 40-year-old female who experienced extrapyramidal symptoms consisting of involuntary movement of the tongue and trismus 30 minutes after methylphenidate administration. The drug was withdrawn, and the patient recovered. The patient was then treated with methylphenidate slow-release and the symptoms were reported to be less severe. The case was first described in a signal published by the Netherlands Pharmacovigilance Centre Lareb.8" ;
              rdfs:label "case 20 info" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#case_22_info
:case_22_info rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Case_Report_Information ;
              OpenPVSignal:has_content "In another case (22), a 21-year-old female experienced trismus two days after administration of methylphenidate. The patient was reported to be recovering without changing the drug treatment. She also used oestrogen with levonorgestrel (treatment with propranolol was also reported which started after trismus occurred)." ;
              rdfs:label "case 22 info" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#case_23_info
:case_23_info rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Case_Report_Information ;
              OpenPVSignal:has_content "Comment: reaction occurred upon abrupt withdrawal of methylphenidate while still on concomitant treatment with antipsychotics. Patient had used the drug for four years but the reaction occurred 33 hours after the last dose." ;
              rdfs:label "case 23 info" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#case_24_info
:case_24_info rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Case_Report_Information ;
              OpenPVSignal:has_content "Comment: reaction occurred upon abrupt reduction of methylphenidate dose (from 80-120 mg to 20 mg). Patient had used the drug for one year and the reaction occurred on the same day as dose was reduced." ,
                                       "In another case (24) the patient was not treated with antipsychotics but still experienced trismus after a rapid decrease in the methylphenidate dose. The patient had used methylphenidate for one year and was normally treated with 80-120 mg/day. On the same day as she took only 20 mg, she developed trismus and jaw pain. The patient was also taking metoprolol and sumatriptan for migraine, both reported as suspected." ;
              rdfs:label "case 24 info" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#case_2_info
:case_2_info rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Case_Report_Information ;
             OpenPVSignal:has_content "Comment: reaction occurred upon abrupt withdrawal of methylphenidate while still on concomitant treatment with antipsychotics The authors of this literature report suspect chronic aripiprazole and methylphenidate usage combined with propofol administration in he short-term absence of methylphenidate made this patient susceptible to dystonic reactions." ;
             rdfs:label "case 2 info" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#case_38_info
:case_38_info rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Case_Report_Information ;
              OpenPVSignal:has_content "The third case (38) describes a 35-year-old female experiencing tightness of jaw muscles within a month after starting methylphenidate treatment which she recovered from without changing the administration of methylphenidate." ;
              rdfs:label "case 38 info" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#case_3_info
:case_3_info rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Case_Report_Information ;
             OpenPVSignal:has_content "Dose not changed/Reaction abated Comment: trismus occurred after methylphenidate dose was increased from 30 to 40 mg. The event then resolved spontaneously without changing the dose." ,
                                      "One case (3) concerned a 29-year-old female who experienced one episode of trismus after increasing the methylphenidate dose from 30 to 40 mg. The adverse event resolved spontaneously, and the patient did not experience similar events later. No other concomitant drugs were reported." ;
             rdfs:label "case 3 info" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#case_info_12
:case_info_12 rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Case_Report_Information ;
              OpenPVSignal:has_content "Comment: patient experienced the adverse reactions after withdrawal of both methylphenidate and diphenhydramine. Patient was treated with methylphenidate for 1.5 years before the withdrawal." ;
              rdfs:label "case 12 info" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#cetirizine
:cetirizine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N03AF01" ;
            rdfs:label "cetirizine" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#chestDiscomfort
:chestDiscomfort rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "R079" ;
                 OpenPVSignal:has_MedDRA_code 10008469 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Chest discomfort" ;
                 rdfs:label "chest discomfort" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#chlorpromazine
:chlorpromazine rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "R06AE07" ;
                rdfs:label "chlorpromazine" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#clonidine
:clonidine rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C02LC01" ,
                                     "C02LC51" ,
                                     "N02CX02" ,
                                     "N05AA01" ,
                                     "S01EA04" ;
           rdfs:label "clonidine" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#clusterHeadache
:clusterHeadache rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "G44.009" ;
                 OpenPVSignal:has_MedDRA_code 10059133 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Cluster headache" ;
                 rdfs:label "cluster headache" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#conclusion
:conclusion rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Conclusion ;
            OpenPVSignal:has_content """In conclusion, there is a signal for methylphenidate and trismus. Overall, the VigiBase cases presented here support this hypothesis, since:
•	the majority of cases (70%) report methylphenidate as the only suspect drug.
•	eight cases report a positive dechallenge, of which one reported a positive rechallenge.
•	there was a plausible dopamine-altering pharmacological mechanism.
•	trismus is plausible when considering other, more general, labelled events for methylphenidate such as muscle tightness, muscle spasms, and muscle cramps.
•	over-reporting of the association compared with the overall reporting in VigiBase.
Trismus or lockjaw is not labelled for methylphenidate in either the SmPC or the PIL. Similar reactions are described in the label, but they do not specifically refer to the jaw. Patients may not therefore recognize trismus or other jaw-related reactions as an adverse drug reaction and could benefit from clearer labels. It is important that the patient has all the necessary information which might affect their decision to start or continue a specific treatment. Since trismus is likely to be a dystonic reaction and dystonia is not specifically included in the label for methylphenidate, dystonia, as a possible adverse reaction to methylphenidate, should undergo in-depth case-assessment.""" ;
            rdfs:label "conclusion" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#coordinationAbnormal
:coordinationAbnormal rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Adverse_Effect ;
                      OpenPVSignal:has_ICD_code "R278" ;
                      OpenPVSignal:has_MedDRA_code 10010947 ;
                      OpenPVSignal:has_MedDRA_prefered_term "Coordination abnormal" ;
                      rdfs:label "coordination abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#crying
:crying rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_ICD_code "R4583" ;
        OpenPVSignal:has_MedDRA_code 10011469 ;
        OpenPVSignal:has_MedDRA_prefered_term "Crying" ;
        rdfs:label "crying" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#decreasedAppetite
:decreasedAppetite rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "R630" ;
                   OpenPVSignal:has_MedDRA_code 10061428 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Decreased appetite" ;
                   rdfs:label "decreased appetite" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#decreasedEyeContact
:decreasedEyeContact rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_ICD_code "S0550XA" ;
                     OpenPVSignal:has_MedDRA_code 10069633 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Decreased eye contact" ;
                     rdfs:label "decreased eye contact" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#depressedMood
:depressedMood rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "F4321" ;
               OpenPVSignal:has_MedDRA_code 10012374 ;
               OpenPVSignal:has_MedDRA_prefered_term "Depressed mood" ;
               rdfs:label "depressed mood" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#depression
:depression rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "F33" ;
            OpenPVSignal:has_MedDRA_code 10012378 ;
            OpenPVSignal:has_MedDRA_prefered_term "Depression" ;
            rdfs:label "depression" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#dexamfetamine
:dexamfetamine rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "N06BA02" ;
               rdfs:label "dexamfetamine" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#diphenhydramine
:diphenhydramine rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Drug ;
                 OpenPVSignal:has_ATC_code "C02AC01" ,
                                           "D04AA32" ,
                                           "D04AA33" ,
                                           "R06AA02" ;
                 rdfs:label "diphenhydramine" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#disturbanceInAttention
:disturbanceInAttention rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Adverse_Effect ;
                        OpenPVSignal:has_ICD_code "R41840" ;
                        OpenPVSignal:has_MedDRA_code 10013496 ;
                        OpenPVSignal:has_MedDRA_prefered_term "Disturbance in attention" ;
                        rdfs:label "disturbance in attention" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#dizziness
:dizziness rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "R42" ;
           OpenPVSignal:has_MedDRA_code 10013573 ;
           OpenPVSignal:has_MedDRA_prefered_term "Dizziness" ;
           rdfs:label "dizziness" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#drugEffectIncomplete
:drugEffectIncomplete rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Adverse_Effect ;
                      OpenPVSignal:has_MedDRA_code 10082200 ;
                      OpenPVSignal:has_MedDRA_prefered_term "Therapeutic product effect incomplete" ;
                      rdfs:label "drug effect incomplete" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#drugIneffective
:drugIneffective rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "Z1630" ;
                 OpenPVSignal:has_MedDRA_code 10013709 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Drug ineffective" ;
                 rdfs:label "drug ineffective" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#drugInteraction
:drugInteraction rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "T887XXA" ;
                 OpenPVSignal:has_MedDRA_code 10013710 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Drug interaction" ;
                 rdfs:label "drug interaction" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#dryMouth
:dryMouth rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R682" ;
          OpenPVSignal:has_MedDRA_code 10013781 ;
          OpenPVSignal:has_MedDRA_prefered_term "Dry mouth" ;
          rdfs:label "dry mouth" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#duloxetine
:duloxetine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "R06AA52" ;
            rdfs:label "duloxetine" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#dyskinesia
:dyskinesia rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "G2401 " ;
            OpenPVSignal:has_MedDRA_code 10013916 ;
            OpenPVSignal:has_MedDRA_prefered_term "Dyskinesia" ;
            rdfs:label "dyskinesia" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#dysphagia
:dysphagia rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "G24" ;
           OpenPVSignal:has_MedDRA_code 10013950 ;
           OpenPVSignal:has_MedDRA_prefered_term "Dysphagia" ;
           rdfs:label "dysphagia" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#dyspnoea
:dyspnoea rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R060" ;
          OpenPVSignal:has_MedDRA_code 10013968 ;
          OpenPVSignal:has_MedDRA_prefered_term "Dyspnoea" ;
          rdfs:label "dyspnoea" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#dystonia
:dystonia rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R9401" ;
          OpenPVSignal:has_MedDRA_code 10013983 ;
          OpenPVSignal:has_MedDRA_prefered_term "Dystonia" ;
          rdfs:label "dystonia" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#earPain
:earPain rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "H92.09" ;
         OpenPVSignal:has_MedDRA_code 10014020 ;
         OpenPVSignal:has_MedDRA_prefered_term "Ear pain" ;
         rdfs:label "ear pain" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#eatingDisorder
:eatingDisorder rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "F50.9" ;
                OpenPVSignal:has_MedDRA_code 10014062 ;
                OpenPVSignal:has_MedDRA_prefered_term "Eating disorder" ;
                rdfs:label "eating disorder" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#ethinylestradiol
:ethinylestradiol rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Drug ;
                  OpenPVSignal:has_ATC_code "G03CA01 " ;
                  rdfs:label "ethinylestradiol" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#extrapyramidalDisorder
:extrapyramidalDisorder rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Adverse_Effect ;
                        OpenPVSignal:has_ICD_code "G259" ;
                        OpenPVSignal:has_MedDRA_code 10015832 ;
                        OpenPVSignal:has_MedDRA_prefered_term "Extrapyramidal disorder" ;
                        rdfs:label "extrapyramidal disorder" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#eyeDisorder
:eyeDisorder rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "R609" ;
             OpenPVSignal:has_MedDRA_code 10015916 ;
             OpenPVSignal:has_MedDRA_prefered_term "Eye disorder" ;
             rdfs:label "eye disorder" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#facialPain
:facialPain rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "G50.1" ;
            OpenPVSignal:has_MedDRA_code 10016059 ;
            OpenPVSignal:has_MedDRA_prefered_term "Facial pain" ;
            rdfs:label "facial pain" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#facialSpasm
:facialSpasm rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "G51.3" ;
             OpenPVSignal:has_MedDRA_code 10063006 ;
             OpenPVSignal:has_MedDRA_prefered_term "Facial spasm" ;
             rdfs:label "facial spasm" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#fatigue
:fatigue rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "R53" ;
         OpenPVSignal:has_MedDRA_code 10016256 ;
         OpenPVSignal:has_MedDRA_prefered_term "Fatigue" ;
         rdfs:label "fatigue" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#feelingJittery
:feelingJittery rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "R45.0" ;
                OpenPVSignal:has_MedDRA_code 10016338 ;
                OpenPVSignal:has_MedDRA_prefered_term "Feeling jittery" ;
                rdfs:label "feeling jittery" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#fentanyl
:fentanyl rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "N01AH01" ,
                                    "N01AH51" ,
                                    "N06AX21" ;
          rdfs:label "fentanyl" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#fingerDeformity
:fingerDeformity rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "M20.099" ;
                 OpenPVSignal:has_MedDRA_code 10061156 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Finger deformity" ;
                 rdfs:label "finger deformity" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#gaitDisturbance
:gaitDisturbance rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "R26" ;
                 OpenPVSignal:has_MedDRA_code 10017577 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Gait disturbance" ;
                 rdfs:label "gait disturbance" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#gingivalDisorder
:gingivalDisorder rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "K06.9" ;
                  OpenPVSignal:has_MedDRA_code 10018280 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Gingival disorder" ;
                  rdfs:label "gingival disorder" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#headache
:headache rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R51" ;
          OpenPVSignal:has_MedDRA_code 10019211 ;
          OpenPVSignal:has_MedDRA_prefered_term "Headache" ;
          rdfs:label "headache" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#homicidalIdeation
:homicidalIdeation rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "S01552A" ;
                   OpenPVSignal:has_MedDRA_code 10049666 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Homicidal ideation" ;
                   rdfs:label "homicidal ideation" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#hyperacusis
:hyperacusis rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "H93233" ;
             OpenPVSignal:has_MedDRA_code 10020559 ;
             OpenPVSignal:has_MedDRA_prefered_term "Hyperacusis" ;
             rdfs:label "hyperacusis" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#hyperhidrosis
:hyperhidrosis rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "R61" ;
               OpenPVSignal:has_MedDRA_code 10020642 ;
               OpenPVSignal:has_MedDRA_prefered_term "Hyperhidrosis" ;
               rdfs:label "hyperhidrosis" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#hypersensitivity
:hypersensitivity rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "T7840XA" ;
                  OpenPVSignal:has_MedDRA_code 10020751 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Hypersensitivity" ;
                  rdfs:label "hypersensitivity" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#hypertension
:hypertension rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "I10" ;
              OpenPVSignal:has_MedDRA_code 10020772 ;
              OpenPVSignal:has_MedDRA_prefered_term "Hypertension" ;
              rdfs:label "hypertension" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#hypertonia
:hypertonia rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "P941" ;
            OpenPVSignal:has_MedDRA_code 10020852 ;
            OpenPVSignal:has_MedDRA_prefered_term "Hypertonia" ;
            rdfs:label "hypertonia" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#hypoaesthesia
:hypoaesthesia rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "R201" ;
               OpenPVSignal:has_MedDRA_code 10020937 ;
               OpenPVSignal:has_MedDRA_prefered_term "Hypoaesthesia" ;
               rdfs:label "hypoaesthesia" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#hypoaesthesiaOral
:hypoaesthesiaOral rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "R20.1" ;
                   OpenPVSignal:has_MedDRA_code 10057371 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Hypoaesthesia oral" ;
                   rdfs:label "hypoaesthesia oral" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#iloperidone
:iloperidone rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "N02AB03" ;
             rdfs:label "iloperidone" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#insomnia
:insomnia rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "G470" ;
          OpenPVSignal:has_MedDRA_code 10022437 ;
          OpenPVSignal:has_MedDRA_prefered_term "Insomnia" ;
          rdfs:label "insomnia" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#intentionalself-Injury
:intentionalself-Injury rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Adverse_Effect ;
                        OpenPVSignal:has_ICD_code "X83" ;
                        OpenPVSignal:has_MedDRA_code 10022524 ;
                        OpenPVSignal:has_MedDRA_prefered_term "Intentional self-injury" ;
                        rdfs:label "intentional self- injury" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#irritability
:irritability rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "R45.4" ;
              OpenPVSignal:has_MedDRA_code 10022998 ;
              OpenPVSignal:has_MedDRA_prefered_term "Irritability" ;
              rdfs:label "irritability" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#jawDisorder
:jawDisorder rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "R8299" ;
             OpenPVSignal:has_MedDRA_code 10061257 ;
             OpenPVSignal:has_MedDRA_prefered_term "Jaw disorder" ;
             rdfs:label "jaw disorder" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#jawStiffness
:jawStiffness rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "M25.60" ;
              OpenPVSignal:has_MedDRA_code 10023230 ;
              OpenPVSignal:has_MedDRA_prefered_term "Joint stiffness" ;
              rdfs:label "jaw stiffness" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#jointStiffness
:jointStiffness rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "M25.60" ;
                OpenPVSignal:has_MedDRA_code 10023230 ;
                OpenPVSignal:has_MedDRA_prefered_term "Joint stiffness" ;
                rdfs:label "joint stiffness" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#levonorgestrel
:levonorgestrel rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "G03AA07" ,
                                          "G03AB03" ,
                                          "G03AC03" ,
                                          "G03FA11" ,
                                          "G03FB09" ,
                                          "N05AX14" ;
                rdfs:label "levonorgestrel" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#lisdexamfetamine
:lisdexamfetamine rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Drug ;
                  OpenPVSignal:has_ATC_code "G03AD01" ;
                  rdfs:label "lisdexamfetamine" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#lithium
:lithium rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Drug ;
         OpenPVSignal:has_ATC_code "D11AX04" ,
                                   "N06BA12" ;
         rdfs:label "lithium" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#logorrhoea
:logorrhoea rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_MedDRA_code 10024796 ;
            OpenPVSignal:has_MedDRA_prefered_term "Logorrhoea" ;
            rdfs:label "logorrhoea" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#masticationDisorder
:masticationDisorder rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_ICD_code "M79.11" ;
                     OpenPVSignal:has_MedDRA_code 10026882 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Mastication disorder" ;
                     rdfs:label "mastication disorder" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#metformin
:metformin rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "A10BA02" ,
                                     "A10BD02" ,
                                     "A10BD03" ,
                                     "A10BD05" ,
                                     "A10BD07" ,
                                     "A10BD08" ,
                                     "A10BD10" ,
                                     "A10BD13" ,
                                     "A10BD14" ,
                                     "A10BD15" ,
                                     "A10BD16" ,
                                     "A10BD17" ,
                                     "A10BD18" ,
                                     "A10BD20" ,
                                     "N05AN01" ;
           rdfs:label "metformin" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#methylphenidate
:methylphenidate rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Drug ;
                 OpenPVSignal:has_mechanism :Mechanism_of_Methylphenydate ,
                                            :Mechanism_of_dystonia ,
                                            :Proposed_mechanism_of_dystonic_reaction ;
                 OpenPVSignal:has_ATC_code "A10BD11" ,
                                           "N06BA04" ,
                                           "N06BA04 " ;
                 rdfs:label "methylphenidate" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#metoprolol
:metoprolol rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C07AB02" ,
                                      "C07AB52" ,
                                      "C07BB02" ,
                                      "C07BB52" ,
                                      "C07CB02" ,
                                      "N06BA04" ;
            rdfs:label "metoprolol" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#mobilityDecreased
:mobilityDecreased rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "Z74.09" ;
                   OpenPVSignal:has_MedDRA_code 10048334 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Mobility decreased" ;
                   rdfs:label "mobility decreased" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#montelukast
:montelukast rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "C07FB02" ,
                                       "R03DC53" ;
             rdfs:label "montelukast" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#moodAltered
:moodAltered rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "F39" ;
             OpenPVSignal:has_MedDRA_code 10027940 ;
             OpenPVSignal:has_MedDRA_prefered_term "Mood altered" ;
             rdfs:label "mood altered" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#mouthSwelling
:mouthSwelling rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "R22.0" ;
               OpenPVSignal:has_MedDRA_code 10075203 ;
               OpenPVSignal:has_MedDRA_prefered_term "Mouth swelling" ;
               rdfs:label "mouth swelling" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#muscleContracture
:muscleContracture rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "M62.40" ;
                   OpenPVSignal:has_MedDRA_code 10062575 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Muscle contracture" ;
                   rdfs:label "muscle contracture" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#muscleSpasms
:muscleSpasms rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "M62838" ;
              OpenPVSignal:has_MedDRA_code 10028334 ;
              OpenPVSignal:has_MedDRA_prefered_term "Muscle spasms" ;
              rdfs:label "muscle spasms" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#muscleTwitching
:muscleTwitching rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "M62.838" ;
                 OpenPVSignal:has_MedDRA_code 10028347 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Muscle twitching" ;
                 rdfs:label "muscle twitching" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#muscle_cramps
:muscle_cramps rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_MedDRA_code 10028295 ;
               OpenPVSignal:has_MedDRA_prefered_term "Muscle cramps" ;
               rdfs:label "muscle cramps" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#muscle_pain
:muscle_pain rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_MedDRA_code 10028322 ;
             OpenPVSignal:has_MedDRA_prefered_term "Muscle pain" ;
             rdfs:label "muscle pain" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#muscle_tightness
:muscle_tightness rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_MedDRA_code 10049816 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Muscle tightness" ;
                  rdfs:label "muscle tightness" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#musculoskeletalStiffness
:musculoskeletalStiffness rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Adverse_Effect ;
                          OpenPVSignal:has_ICD_code "M2560" ;
                          OpenPVSignal:has_MedDRA_code 10052904 ;
                          OpenPVSignal:has_MedDRA_prefered_term "Musculoskeletal stiffness" ;
                          rdfs:label "musculoskeletal stiffness" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#myalgia
:myalgia rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "M791" ;
         OpenPVSignal:has_MedDRA_code 10028411 ;
         OpenPVSignal:has_MedDRA_prefered_term "Myalgia" ;
         rdfs:label "myalgia" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#neurologicalSymptom
:neurologicalSymptom rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_MedDRA_code 10060860 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Neurological symptom" ;
                     rdfs:label "neurological symptom" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#omeprazole
:omeprazole rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "A02BC01" ,
                                      "A02BD01" ,
                                      "R03DC03" ;
            rdfs:label "omeprazole" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#oppositionalDefiantDisorder
:oppositionalDefiantDisorder rdf:type owl:NamedIndividual ,
                                      OpenPVSignal:Adverse_Effect ;
                             OpenPVSignal:has_ICD_code "A499" ;
                             OpenPVSignal:has_MedDRA_code 10056440 ;
                             OpenPVSignal:has_MedDRA_prefered_term "Oppositional defiant disorder" ;
                             rdfs:label "oppositional defiant disorder" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#oromandibularDystonia
:oromandibularDystonia rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Adverse_Effect ;
                       OpenPVSignal:has_ICD_code "G24.4" ;
                       OpenPVSignal:has_MedDRA_code 10067954 ;
                       OpenPVSignal:has_MedDRA_prefered_term "Oromandibular dystonia" ;
                       rdfs:label "oromandibular dystonia" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#overallReportsFromVigiBaseAfterDuplicateRemoval
:overallReportsFromVigiBaseAfterDuplicateRemoval rdf:type owl:NamedIndividual ,
                                                          OpenPVSignal:Reports_group ;
                                                 OpenPVSignal:refers_to_drug :methylphenidate ;
                                                 OpenPVSignal:refers_to_unconfirmed_adverse_effect :Jaw_joint_rigid_state_of ,
                                                                                                   :jawStiffness ,
                                                                                                   :tightnessInJaw ,
                                                                                                   :tightnessOfJawMuscles ,
                                                                                                   :trismus ;
                                                 OpenPVSignal:has_average_age 25 ;
                                                 OpenPVSignal:has_count 38 ;
                                                 OpenPVSignal:has_count_of_men 20 ;
                                                 OpenPVSignal:has_count_of_women 17 ;
                                                 OpenPVSignal:has_max_age "60.0"^^xsd:float ;
                                                 OpenPVSignal:has_median_age "21.0"^^xsd:float ;
                                                 OpenPVSignal:has_min_age "5.0"^^xsd:float ;
                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                 rdfs:label "overall reports from VigiBase after duplicate removal" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#oxybateSodium
:oxybateSodium rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "N07XX04 " ;
               rdfs:label "oxybate sodium " .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#pain
:pain rdf:type owl:NamedIndividual ,
               OpenPVSignal:Adverse_Effect ;
      OpenPVSignal:has_ICD_code "G891" ;
      OpenPVSignal:has_MedDRA_code 10033371 ;
      OpenPVSignal:has_MedDRA_prefered_term "Pain" ;
      rdfs:label "pain" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#painInJaw
:painInJaw rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "R68.84" ;
           OpenPVSignal:has_MedDRA_code 10033433 ;
           OpenPVSignal:has_MedDRA_prefered_term "Pain in jaw" ;
           rdfs:label "pain in jaw" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#palpitations
:palpitations rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "R002" ;
              OpenPVSignal:has_MedDRA_code 10033557 ;
              OpenPVSignal:has_MedDRA_prefered_term "Palpitations" ;
              rdfs:label "palpitations" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#paraesthesia
:paraesthesia rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "R202" ;
              OpenPVSignal:has_MedDRA_code 10033775 ;
              OpenPVSignal:has_MedDRA_prefered_term "Paraesthesia" ;
              rdfs:label "paraesthesia" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#paroxetine
:paroxetine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "A02BD05" ;
            rdfs:label "paroxetine" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#patient_13
:patient_13 rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Patient ;
            OpenPVSignal:has_age 5 ;
            OpenPVSignal:has_gender "male" ;
            rdfs:label "patient 13" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#patient_17
:patient_17 rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Patient ;
            OpenPVSignal:has_age 14 ;
            OpenPVSignal:has_gender "male" ;
            rdfs:label "patient 17" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#patient_18
:patient_18 rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Patient ;
            OpenPVSignal:has_age 5 ;
            OpenPVSignal:has_gender "male" ;
            rdfs:label "patient 18" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#patient_20
:patient_20 rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Patient ;
            OpenPVSignal:has_age 40 ;
            OpenPVSignal:has_gender "female" ;
            rdfs:label "patient 20" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#patient_26
:patient_26 rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Patient ;
            OpenPVSignal:has_age 11 ;
            OpenPVSignal:has_gender "male" ;
            rdfs:label "patient 26" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#patient_30
:patient_30 rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Patient ;
            OpenPVSignal:has_age 8 ;
            OpenPVSignal:has_gender "male" ;
            rdfs:label "patient 30" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#patient_31
:patient_31 rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Patient ;
            OpenPVSignal:has_age 41 ;
            OpenPVSignal:has_gender "female" ;
            rdfs:label "patient 31" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#patient_34
:patient_34 rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Patient ;
            OpenPVSignal:has_age 34 ;
            OpenPVSignal:has_gender "female" ;
            rdfs:label "patient 34" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#patient_35
:patient_35 rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Patient ;
            OpenPVSignal:has_age 15 ;
            OpenPVSignal:has_gender "male" ;
            rdfs:label "patient 35" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#patient_36
:patient_36 rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Patient ;
            OpenPVSignal:has_age 8 ;
            OpenPVSignal:has_gender "male" ;
            rdfs:label "patient 36" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#peripheralColdness
:peripheralColdness rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_ICD_code "R20.9" ;
                    OpenPVSignal:has_MedDRA_code 10034568 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Peripheral coldness" ;
                    rdfs:label "peripheral coldness" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#poorQualitySleep
:poorQualitySleep rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "G479" ;
                  OpenPVSignal:has_MedDRA_code 10062519 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Poor quality sleep" ;
                  rdfs:label "poor quality sleep" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#propofol
:propofol rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "N06AB05" ;
          rdfs:label "propofol" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#propranolol
:propranolol rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "C07AA05" ,
                                       "C07BA05" ,
                                       "N01AX10" ;
             rdfs:label "propranolol" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#psychomotorHyperactivity
:psychomotorHyperactivity rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Adverse_Effect ;
                          OpenPVSignal:has_ICD_code "R41843" ;
                          OpenPVSignal:has_MedDRA_code 10037211 ;
                          OpenPVSignal:has_MedDRA_prefered_term "Psychomotor hyperactivity" ;
                          rdfs:label "psychomotor hyperactivity" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#pvSignal
:pvSignal rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Signal ;
          OpenPVSignal:Free_text_reporting_element :Discussion ,
                                                   :Dyskinesia_pathology ,
                                                   :Dystonia_pathology ,
                                                   :Introduction_content ,
                                                   :Reports_in_VigiBase ,
                                                   :Summary_content ,
                                                   :conclusion ,
                                                   <http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Trismus/lockjaw_pathology> ;
          OpenPVSignal:is_supported_by_individual_case_report :Report1 ,
                                                              :Report10 ,
                                                              :Report11 ,
                                                              :Report12 ,
                                                              :Report13 ,
                                                              :Report14 ,
                                                              :Report15 ,
                                                              :Report16 ,
                                                              :Report17 ,
                                                              :Report18 ,
                                                              :Report19 ,
                                                              :Report2 ,
                                                              :Report20 ,
                                                              :Report21 ,
                                                              :Report22 ,
                                                              :Report23 ,
                                                              :Report24 ,
                                                              :Report25 ,
                                                              :Report26 ,
                                                              :Report27 ,
                                                              :Report28 ,
                                                              :Report29 ,
                                                              :Report3 ,
                                                              :Report30 ,
                                                              :Report31 ,
                                                              :Report32 ,
                                                              :Report33 ,
                                                              :Report34 ,
                                                              :Report35 ,
                                                              :Report36 ,
                                                              :Report37 ,
                                                              :Report38 ,
                                                              :Report4 ,
                                                              :Report5 ,
                                                              :Report6 ,
                                                              :Report7 ,
                                                              :Report8 ,
                                                              :Report9 ;
          OpenPVSignal:is_supported_by_statistical_entity :overallReportsFromVigiBaseAfterDuplicateRemoval ,
                                                          :reportsForTrismus ,
                                                          :reportsObservedInVigiBaseForTrismusAndMethylphenidate ,
                                                          :reportsWithAbatingReaction ,
                                                          :reportsWithMethylphenidateAsTheOnlySuspect ,
                                                          :reportsWithMethylphenidateWithdrawal ,
                                                          :reportsWithNoEffectAfterDrugWithdrawal ,
                                                          :reportsWithPositiveDechallenge ,
                                                          :reportsWithPositiveDechallengeAndMethylphenidateAsOnlyOutcome ,
                                                          :reportsWithTTOInformation ,
                                                          :reportsWithUnknownOutcome ,
                                                          :reports_from_Canada ,
                                                          :reports_from_Denmark ,
                                                          :reports_from_France ,
                                                          :reports_from_Iceland ,
                                                          :reports_from_Netherlands ,
                                                          :reports_from_New_Zealand ,
                                                          :reports_from_Norway ,
                                                          :reports_from_South_Africa ,
                                                          :reports_from_USA ,
                                                          :reports_in_vigibase_with_methylphenidate_and_dystonias ,
                                                          :reports_with_concomitant_antipsychotics ,
                                                          :reports_with_trismus_resolved_without_treatment_changing ;
          OpenPVSignal:refers_to_drug :methylphenidate ;
          OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
          OpenPVSignal:refers_to_unconfirmed_adverse_effect :Jaw_joint_rigid_state_of ,
                                                            :jawStiffness ,
                                                            :tightnessInJaw ,
                                                            :tightnessOfJawMuscles ,
                                                            :trismus ;
          mp:supportedByData :Antipsychotics_and_dystonia ,
                             :Labelling_for_methylphenidate ,
                             :Lareb_report ,
                             :Methylphenidate_and_dyskinesia ,
                             :Tekin_et_al_report ,
                             :UK_PIL ,
                             :Uzun_et_al_report ;
          OpenPVSignal:initially_identified_on "01/08/2019" ;
          rdfs:label "pv signal" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#quetiapine
:quetiapine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C07FA05" ;
            rdfs:label "quetiapine" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reportsForTrismus
:reportsForTrismus rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Reports_group ;
                   OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                   OpenPVSignal:refers_to_drug :methylphenidate ;
                   OpenPVSignal:refers_to_unconfirmed_adverse_effect :trismus ;
                   OpenPVSignal:has_count 29 ;
                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                   rdfs:label "reports for trismus" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reportsObservedInVigiBaseForTrismusAndMethylphenidate
:reportsObservedInVigiBaseForTrismusAndMethylphenidate rdf:type owl:NamedIndividual ,
                                                                OpenPVSignal:Reports_group ;
                                                       OpenPVSignal:refers_to_drug :methylphenidate ;
                                                       OpenPVSignal:refers_to_unconfirmed_adverse_effect :trismus ;
                                                       OpenPVSignal:has_count 27 ;
                                                       OpenPVSignal:has_expected_count "8.3"^^xsd:float ;
                                                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                       rdfs:label "reports observed in VigiBase for trismus and methylphenidate" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reportsWithAbatingReaction
:reportsWithAbatingReaction rdf:type owl:NamedIndividual ,
                                     OpenPVSignal:Reports_group ;
                            OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                            OpenPVSignal:has_count 8 ;
                            OpenPVSignal:refers_to_database "WHO Vigibase" ;
                            OpenPVSignal:refers_to_outcome_after_action "recovery after drug withdrawal" ;
                            rdfs:label "reports with abating reaction" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reportsWithMethylphenidateAsTheOnlySuspect
:reportsWithMethylphenidateAsTheOnlySuspect rdf:type owl:NamedIndividual ,
                                                     OpenPVSignal:Reports_group ;
                                            OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                                            OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
                                            OpenPVSignal:has_count 27 ;
                                            OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                            rdfs:label "reports with methylphenidate as the only suspect" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reportsWithMethylphenidateWithdrawal
:reportsWithMethylphenidateWithdrawal rdf:type owl:NamedIndividual ,
                                               OpenPVSignal:Reports_group ;
                                      OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                                      OpenPVSignal:has_count 14 ;
                                      OpenPVSignal:refers_to_challenge_type "Dechallenge" ;
                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                      rdfs:label "reports with methylphenidate withdrawal" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reportsWithNoEffectAfterDrugWithdrawal
:reportsWithNoEffectAfterDrugWithdrawal rdf:type owl:NamedIndividual ,
                                                 OpenPVSignal:Reports_group ;
                                        OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                                        OpenPVSignal:has_count 4 ;
                                        OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                        OpenPVSignal:refers_to_dechallenge_outcome "negative - condition still applied" ;
                                        OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
                                        rdfs:label "reports with no effect after drug withdrawal" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reportsWithPositiveDechallenge
:reportsWithPositiveDechallenge rdf:type owl:NamedIndividual ,
                                         OpenPVSignal:Reports_group ;
                                OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                                OpenPVSignal:has_count 8 ;
                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
                                rdfs:label "reports with positive dechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reportsWithPositiveDechallengeAndMethylphenidateAsOnlyOutcome
:reportsWithPositiveDechallengeAndMethylphenidateAsOnlyOutcome rdf:type owl:NamedIndividual ,
                                                                        OpenPVSignal:Reports_group ;
                                                               OpenPVSignal:is_subgroup_of :reportsWithPositiveDechallenge ;
                                                               OpenPVSignal:refers_to_primary_suspect_drug :methylphenidate ;
                                                               OpenPVSignal:has_count 7 ;
                                                               OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                               rdfs:label "reports with positive dechallenge and methylphenidate as only outcome" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reportsWithTTOInformation
:reportsWithTTOInformation rdf:type owl:NamedIndividual ,
                                    OpenPVSignal:Reports_group ;
                           OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                           OpenPVSignal:time_to_onset :Time_to_onset_info ;
                           OpenPVSignal:has_count 22 ;
                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                           rdfs:label "reports with TTO information" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reportsWithUnknownOutcome
:reportsWithUnknownOutcome rdf:type owl:NamedIndividual ,
                                    OpenPVSignal:Reports_group ;
                           OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                           OpenPVSignal:has_count 3 ;
                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                           OpenPVSignal:refers_to_dechallenge_outcome "unknown" ;
                           OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                           rdfs:label "reports with unknown outcome" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reports_from_Canada
:reports_from_Canada rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Reports_group ;
                     OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                     OpenPVSignal:has_count 3 ;
                     OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Canada" ;
                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                     rdfs:label "reports from Canada" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reports_from_Denmark
:reports_from_Denmark rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Reports_group ;
                      OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                      OpenPVSignal:has_count 1 ;
                      OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Denmark" ;
                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                      rdfs:label "reports from Denmark" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reports_from_France
:reports_from_France rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Reports_group ;
                     OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                     OpenPVSignal:has_count 2 ;
                     OpenPVSignal:refers_to_country "http://dbpedia.org/resource/France" ;
                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                     rdfs:label "reports from France" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reports_from_Iceland
:reports_from_Iceland rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Reports_group ;
                      OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                      OpenPVSignal:has_count 1 ;
                      OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Iceland" ;
                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                      rdfs:label "reports from Iceland" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reports_from_Netherlands
:reports_from_Netherlands rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Reports_group ;
                          OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                          OpenPVSignal:has_count 14 ;
                          OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Netherlands" ;
                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                          rdfs:label "reports from Netherlands" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reports_from_New_Zealand
:reports_from_New_Zealand rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Reports_group ;
                          OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                          OpenPVSignal:has_count 1 ;
                          OpenPVSignal:refers_to_country "http://dbpedia.org/resource/New_Zealand" ;
                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                          rdfs:label "reports from New Zealand" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reports_from_Norway
:reports_from_Norway rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Reports_group ;
                     OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                     OpenPVSignal:has_count 1 ;
                     OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Norway" ;
                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                     rdfs:label "reports from Norway" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reports_from_South_Africa
:reports_from_South_Africa rdf:type owl:NamedIndividual ,
                                    OpenPVSignal:Reports_group ;
                           OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                           OpenPVSignal:has_count 1 ;
                           OpenPVSignal:refers_to_country "http://dbpedia.org/resource/South_Africa" ;
                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                           rdfs:label "reports from South Africa" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reports_from_USA
:reports_from_USA rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Reports_group ;
                  OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                  OpenPVSignal:has_count 14 ;
                  OpenPVSignal:refers_to_country "http://dbpedia.org/resource/United_States" ;
                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                  rdfs:label "reports from USA" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reports_in_vigibase_with_methylphenidate_and_dystonias
:reports_in_vigibase_with_methylphenidate_and_dystonias rdf:type owl:NamedIndividual ,
                                                                 OpenPVSignal:Reports_group ;
                                                        OpenPVSignal:refers_to_adverse_effect :dystonia ;
                                                        OpenPVSignal:refers_to_drug :methylphenidate ;
                                                        OpenPVSignal:has_count 213 ;
                                                        OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                        rdfs:label "reports in vigibase with methylphenidate and dystonias" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reports_with_concomitant_antipsychotics
:reports_with_concomitant_antipsychotics rdf:type owl:NamedIndividual ,
                                                  OpenPVSignal:Reports_group ;
                                         OpenPVSignal:is_subgroup_of :reports_in_vigibase_with_methylphenidate_and_dystonias ;
                                         OpenPVSignal:refers_to_class :antipsychotics ;
                                         OpenPVSignal:has_count 74 ;
                                         OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                         rdfs:label "reports with concomitant antipsychotics" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#reports_with_trismus_resolved_without_treatment_changing
:reports_with_trismus_resolved_without_treatment_changing rdf:type owl:NamedIndividual ,
                                                                   OpenPVSignal:Reports_group ;
                                                          OpenPVSignal:is_subgroup_of :overallReportsFromVigiBaseAfterDuplicateRemoval ;
                                                          OpenPVSignal:refers_to_unconfirmed_adverse_effect :trismus ;
                                                          OpenPVSignal:has_count 3 ;
                                                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                          OpenPVSignal:refers_to_outcome_after_action "recovery without drug withdrawal" ;
                                                          rdfs:label "reports with trismus resolved without treatment changing" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#restlessness
:restlessness rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "R451" ;
              OpenPVSignal:has_MedDRA_code 10038743 ;
              OpenPVSignal:has_MedDRA_prefered_term "Restlessness" ;
              rdfs:label "restlessness" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#risperidone
:risperidone rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "N05AH04" ,
                                       "N05AX08 " ;
             rdfs:label "risperidone" ,
                        "risperidone " .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#rocuronium
:rocuronium rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N05AX08" ;
            rdfs:label "rocuronium" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#salbutamol
:salbutamol rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "M03AC09" ,
                                      "R03AC02" ,
                                      "R03AL02" ,
                                      "R03CC02" ;
            rdfs:label "salbutamol" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#sedation
:sedation rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_MedDRA_code 10039897 ;
          OpenPVSignal:has_MedDRA_prefered_term "Sedation" ;
          rdfs:label "sedation" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#sevoflurane
:sevoflurane rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "R03AK04" ;
             rdfs:label "sevoflurane" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#simvastatin
:simvastatin rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "A10BH51" ,
                                       "C10AA01" ,
                                       "C10BA02" ,
                                       "C10BA04" ,
                                       "C10BX04" ,
                                       "N01AB08" ;
             rdfs:label "simvastatin" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#sleepDisorder
:sleepDisorder rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "G479" ;
               OpenPVSignal:has_MedDRA_code 10040984 ;
               OpenPVSignal:has_MedDRA_prefered_term "Sleep disorder" ;
               rdfs:label "sleep disorder" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#somnolence
:somnolence rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "R40" ;
            OpenPVSignal:has_MedDRA_code 10041349 ;
            OpenPVSignal:has_MedDRA_prefered_term "Somnolence" ;
            rdfs:label "somnolence" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#speechDisorder
:speechDisorder rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "F809" ;
                OpenPVSignal:has_MedDRA_code 10041466 ;
                OpenPVSignal:has_MedDRA_prefered_term "Speech disorder" ;
                rdfs:label "speech disorder" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#streptococcalInfection
:streptococcalInfection rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Adverse_Effect ;
                        OpenPVSignal:has_ICD_code "A491" ;
                        OpenPVSignal:has_MedDRA_code 10061372 ;
                        OpenPVSignal:has_MedDRA_prefered_term "Streptococcal infection" ;
                        rdfs:label "streptococcal infection" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#suicidalIdeation
:suicidalIdeation rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "R45851" ;
                  OpenPVSignal:has_MedDRA_code 10042458 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Suicidal ideation" ;
                  rdfs:label "suicidal ideation" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#sumatriptan
:sumatriptan rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "C10BX01" ,
                                       "G01AE10" ;
             rdfs:label "sumatriptan" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#swollenTongue
:swollenTongue rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "R22.0" ;
               OpenPVSignal:has_MedDRA_code 10042727 ;
               OpenPVSignal:has_MedDRA_prefered_term "Swollen tongue" ;
               rdfs:label "swollen tongue" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#tachycardia
:tachycardia rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "R000" ;
             OpenPVSignal:has_MedDRA_code 10043071 ;
             OpenPVSignal:has_MedDRA_prefered_term "Tachycardia" ;
             rdfs:label "tachycardia" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#teeth_clenching
:teeth_clenching rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_MedDRA_code 10057326 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Teeth clenching" ;
                 rdfs:label "teeth clenching" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#teeth_grinding
:teeth_grinding rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_MedDRA_code 10043176 ;
                OpenPVSignal:has_MedDRA_prefered_term "Teeth grinding" ;
                rdfs:label "teeth grinding" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#tensionHeadache
:tensionHeadache rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "G44209" ;
                 OpenPVSignal:has_MedDRA_code 10043269 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Tension headache" ;
                 rdfs:label "tension headache" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#therapeuticResponseUnexpected
:therapeuticResponseUnexpected rdf:type owl:NamedIndividual ,
                                        OpenPVSignal:Adverse_Effect ;
                               OpenPVSignal:has_ICD_code "T887" ;
                               OpenPVSignal:has_MedDRA_code 10043417 ;
                               OpenPVSignal:has_MedDRA_prefered_term "Therapeutic response unexpected" ;
                               rdfs:label "therapeutic response unexpected" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#tic
:tic rdf:type owl:NamedIndividual ,
              OpenPVSignal:Adverse_Effect ;
     OpenPVSignal:has_ICD_code "K149" ;
     OpenPVSignal:has_MedDRA_code 10043833 ;
     OpenPVSignal:has_MedDRA_prefered_term "Tic" ;
     rdfs:label "tic" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#tightnessInJaw
:tightnessInJaw rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "R68.84" ;
                OpenPVSignal:has_MedDRA_code 10049816 ;
                OpenPVSignal:has_MedDRA_prefered_term "Muscle tightness" ;
                rdfs:label "tightness in jaw" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#tightnessOfJawMuscles
:tightnessOfJawMuscles rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Adverse_Effect ;
                       OpenPVSignal:has_ICD_code "R68.84" ;
                       OpenPVSignal:has_MedDRA_code 10049816 ;
                       OpenPVSignal:has_MedDRA_prefered_term "Muscle tightness" ;
                       rdfs:label "tightness of jaw muscles" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#tongueBiting
:tongueBiting rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "Z9114" ;
              OpenPVSignal:has_MedDRA_code 10050467 ;
              OpenPVSignal:has_MedDRA_prefered_term "Tongue biting" ;
              rdfs:label "tongue biting" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#tongueDisorderCondition
:tongueDisorderCondition rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Adverse_Effect ;
                         OpenPVSignal:has_ICD_code "R32" ;
                         OpenPVSignal:has_MedDRA_code 10043951 ;
                         OpenPVSignal:has_MedDRA_prefered_term "Tongue disorder" ;
                         rdfs:label "tongue disorder condition" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#tongueSpasm
:tongueSpasm rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "K14.8" ;
             OpenPVSignal:has_MedDRA_code 10043981 ;
             OpenPVSignal:has_MedDRA_prefered_term "Tongue spasm" ;
             rdfs:label "tongue spasm" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#torticollis
:torticollis rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "M436" ;
             OpenPVSignal:has_MedDRA_code 10044074 ;
             OpenPVSignal:has_MedDRA_prefered_term "Torticollis" ;
             rdfs:label "torticollis" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#tremor
:tremor rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_ICD_code "R251" ;
        OpenPVSignal:has_MedDRA_code 10044565 ;
        OpenPVSignal:has_MedDRA_prefered_term "Tremor" ;
        rdfs:label "tremor" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#trismus
:trismus rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "M26.53" ;
         OpenPVSignal:has_MedDRA_code 10044684 ;
         OpenPVSignal:has_MedDRA_prefered_term "Trismus" ;
         rdfs:label "trismus" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#usage_of_methylphenidate
:usage_of_methylphenidate rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Drug_Usage ;
                          OpenPVSignal:concerns_indication_for_use :AttentionDeficitHyperactivityDisorder ;
                          OpenPVSignal:refers_to_drug :methylphenidate ;
                          rdfs:label "usage of methylphenidate" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#valproicAcid
:valproicAcid rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "N02CC01" ;
              rdfs:label "valproic acid" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#vertigo
:vertigo rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_MedDRA_code 10047340 ;
         OpenPVSignal:has_MedDRA_prefered_term "Vertigo" ;
         rdfs:label "vertigo" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#visionBlurred
:visionBlurred rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "H538" ;
               OpenPVSignal:has_MedDRA_code 10047513 ;
               OpenPVSignal:has_MedDRA_prefered_term "Vision blurred" ;
               rdfs:label "vision blurred" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#weightDecreased
:weightDecreased rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "R634" ;
                 OpenPVSignal:has_MedDRA_code 10047895 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Weight decreased" ;
                 rdfs:label "weight decreased" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#ziprasidone
:ziprasidone rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "N03AG01" ,
                                       "N05AE04" ;
             rdfs:label "ziprasidone" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#-/F
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#-/F> rdf:type owl:NamedIndividual ,
                                                                                       OpenPVSignal:Patient ;
                                                                              OpenPVSignal:has_gender "female" ;
                                                                              rdfs:label "patient 4" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#11/M
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#11/M> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 11 ;
                                                                               OpenPVSignal:has_gender "male" ;
                                                                               rdfs:label "patient 2" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#11/-
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#11/-> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 11 ;
                                                                               rdfs:label "patient 23" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#14/M
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#14/M> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 14 ;
                                                                               OpenPVSignal:has_gender "male" ;
                                                                               rdfs:label "patient 7" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#15/M
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#15/M> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 15 ;
                                                                               OpenPVSignal:has_gender "male" ;
                                                                               rdfs:label "patient 12" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#16/M
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#16/M> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 16 ;
                                                                               OpenPVSignal:has_gender "male" ;
                                                                               rdfs:label "patient 14" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#18/M
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#18/M> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 18 ;
                                                                               OpenPVSignal:has_gender "male" ;
                                                                               rdfs:label "patient 33" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#21/F
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#21/F> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 21 ;
                                                                               OpenPVSignal:has_gender "female" ;
                                                                               rdfs:label "patient 22" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#22/F
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#22/F> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 22 ;
                                                                               OpenPVSignal:has_gender "female" ;
                                                                               rdfs:label "patient 37" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#24/M
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#24/M> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 24 ;
                                                                               OpenPVSignal:has_gender "male" ;
                                                                               rdfs:label "patient 19" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#29/F
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#29/F> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 29 ;
                                                                               OpenPVSignal:has_gender "female" ;
                                                                               rdfs:label "patient 3" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#30/F
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#30/F> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 30 ;
                                                                               OpenPVSignal:has_gender "female" ;
                                                                               rdfs:label "patient 16" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#35/F
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#35/F> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 35 ;
                                                                               OpenPVSignal:has_gender "female" ;
                                                                               rdfs:label "patient 38" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#37/F
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#37/F> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 37 ;
                                                                               OpenPVSignal:has_gender "female" ;
                                                                               rdfs:label "patient 24" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#38/M
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#38/M> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 38 ;
                                                                               OpenPVSignal:has_gender "male" ;
                                                                               rdfs:label "patient 29" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#40/F
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#40/F> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 40 ;
                                                                               OpenPVSignal:has_gender "female" ;
                                                                               rdfs:label "patient 8" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#41/F
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#41/F> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 41 ;
                                                                               OpenPVSignal:has_gender "female" ;
                                                                               rdfs:label "patient 25" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#42/F
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#42/F> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 42 ;
                                                                               OpenPVSignal:has_gender "female" ;
                                                                               rdfs:label "patient 6" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#42/M
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#42/M> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 42 ;
                                                                               OpenPVSignal:has_gender "male" ;
                                                                               rdfs:label "patient 15" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#48/F
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#48/F> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 48 ;
                                                                               OpenPVSignal:has_gender "female" ;
                                                                               rdfs:label "patient 5" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#5/M
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#5/M> rdf:type owl:NamedIndividual ,
                                                                                       OpenPVSignal:Patient ;
                                                                              OpenPVSignal:has_age 5 ;
                                                                              OpenPVSignal:has_gender "male" ;
                                                                              rdfs:label "patient 1" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#55/F
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#55/F> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 55 ;
                                                                               OpenPVSignal:has_gender "female" ;
                                                                               rdfs:label "patient 27" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#59/M
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#59/M> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 59 ;
                                                                               OpenPVSignal:has_gender "male" ;
                                                                               rdfs:label "patient 21" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#6/M
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#6/M> rdf:type owl:NamedIndividual ,
                                                                                       OpenPVSignal:Patient ;
                                                                              OpenPVSignal:has_age 6 ;
                                                                              OpenPVSignal:has_gender "male" ;
                                                                              rdfs:label "patient 9" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#60/M
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#60/M> rdf:type owl:NamedIndividual ,
                                                                                        OpenPVSignal:Patient ;
                                                                               OpenPVSignal:has_age 60 ;
                                                                               OpenPVSignal:has_gender "male" ;
                                                                               rdfs:label "patient 10" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#7/M
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#7/M> rdf:type owl:NamedIndividual ,
                                                                                       OpenPVSignal:Patient ;
                                                                              OpenPVSignal:has_age 7 ;
                                                                              OpenPVSignal:has_gender "male" ;
                                                                              rdfs:label "patient 32" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#8/F
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#8/F> rdf:type owl:NamedIndividual ,
                                                                                       OpenPVSignal:Patient ;
                                                                              OpenPVSignal:has_age 8 ;
                                                                              OpenPVSignal:has_gender "female" ;
                                                                              rdfs:label "patient 28" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#8/M
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#8/M> rdf:type owl:NamedIndividual ,
                                                                                       OpenPVSignal:Patient ;
                                                                              OpenPVSignal:has_age 8 ;
                                                                              OpenPVSignal:has_gender "female" ;
                                                                              rdfs:label "patient 11" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Trismus/lockjaw_pathology
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#Trismus/lockjaw_pathology> rdf:type owl:NamedIndividual ,
                                                                                                             OpenPVSignal:Free_text_reporting_element ;
                                                                                                    OpenPVSignal:refers_to_adverse_effect :trismus ;
                                                                                                    mp:references :Ref.4 ;
                                                                                                    OpenPVSignal:has_content "Trismus, or lockjaw, is the inability to open the mouth, usually because of muscle spasms. Causes include physical trauma, oral/dental surgery, infections, and temporomandibular joint disease (e.g. rheumatoid arthritis). Trismus can also be part of a drug-induced dystonic reaction. Antipsychotics (e.g. risperidone, aripiprazole) and antiemetics (e.g. metoclopramide) are known to cause dystonia, and it seems to be caused by an abnormal dopaminergic activity involving the basal ganglia.4" ;
                                                                                                    rdfs:label "Trismus/lockjaw pathophysiology" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#sydenham'sChorea
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#sydenham'sChorea> rdf:type owl:NamedIndividual ,
                                                                                                    OpenPVSignal:Adverse_Effect ;
                                                                                           OpenPVSignal:has_ICD_code "G25.5" ;
                                                                                           OpenPVSignal:has_MedDRA_code 10042732 ;
                                                                                           OpenPVSignal:has_MedDRA_prefered_term "Sydenham's chorea" ;
                                                                                           rdfs:label "sydenham's chorea" .


###  http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#tourette'sDisorder
<http://purl.org/OpenPVSignal/Signals/2019_4_methylphenidate_lockjaw.owl#tourette'sDisorder> rdf:type owl:NamedIndividual ,
                                                                                                      OpenPVSignal:Adverse_Effect ;
                                                                                             OpenPVSignal:has_ICD_code "F95.2" ;
                                                                                             OpenPVSignal:has_MedDRA_code 10044126 ;
                                                                                             OpenPVSignal:has_MedDRA_prefered_term "Tourette's disorder" ;
                                                                                             rdfs:label "tourette's disorder" .


###  Generated by the OWL API (version 4.5.9.2019-02-01T07:24:44Z) https://github.com/owlcs/owlapi
